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ABSTRACT 
Risk Factors for Emerging and Reemerging Infectious Diseases in Children 
Meghan T. Murray 
This dissertation assesses the factors that lead to the emergence of infectious diseases in 
children, particularly the emergence of multidrug-resistant organisms (MDROs) and diarrheal 
pathogens in vulnerable pediatric populations.  It includes three manuscripts.  The initial study is 
a systematic review that summarized the role of antibiotic exposure on the acquisition of 
MDROs in children.  Twenty-nine studies met the inclusion criteria and a positive association 
between prior antibiotic use and subsequent colonization or infection with an MDRO was 
identified in most studies.  There were wide variations among study sites, populations, and 
definitions of antibiotic use and MDROs.  Therefore, limited inferences could be made on which 
components of antibiotic exposure have the greatest impact on MDRO development. 
The second analysis examines the relationship between prior stay at a pediatric long-term 
care (LTC) facility and infection with an MDRO among hospitalized children.  This study 
included 2,945 infections in 258,664 pediatric admissions from 2006 through 2016.   At least 1 
MDRO was identified in 10% of infections.  Of the 1,198 children who had previously resided in 
a pediatric LTC facility, only 1 child (0.08%) had an MDRO infection.  However, prior receipt 
of pediatric LTC was associated with an increased likelihood of infection (OR 2.4, CI95 1.66 – 
3.43), C. difficile infection (OR 2.57, CI95 1.26 – 5.25), days of antibiotic use (OR 1.01, CI95 
1.01 – 1.02), length of stay (OR 1.01, CI95 1.01 – 1.01), and death (OR 4.38, CI95 2.93 – 6.55). 
The concluding study evaluates the association between animals living in or near the 
home and diarrheal disease in children.  This research is a secondary analysis of the Global 
Enteric Multicenter Study case control study, which investigated the epidemiology of diarrheal 
illness in children <5 in sub-Saharan Africa and south Asia.  Of 9,439 cases and 13,128 controls, 
87% had ≥1 animal in their home.  In a multivariable analysis adjusting for exclusive 
breastfeeding, water source, sanitation facility, number of children <5 years in the household, 
and wealth index, any animal on a child’s compound decreased the odds of diarrhea by 33% 
(aOR 0.66, CI95 0.59 – 0.74).   However, children with diarrhea who had an animal present were 
not more likely to have a positive stool culture. 
Overall, the three studies provide a thorough analysis of several factors associated with 
the infectious disease emergence in children, particularly as related to MDROs and diarrheal 
disease.  Environmental characteristics, including antibiotic use and interaction with animals, 
were shown to be important factors for emergent infectious disease across diverse settings.  The 
development of pediatric infection prevention interventions should take into consideration 
environmental risk factors in order to effectively mitigate the risks posed infectious disease 
emergence. 
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Despite advances in infection prevention and the development of antimicrobial therapies, 
infectious diseases have remained a significant cause of global morbidity and mortality.  
According to the World Health Organization, infectious diseases cause about a quarter of deaths 
worldwide and are a significant contributor to lifetime disability (1, 2).  In 2016, infectious 
diseases were responsible for almost 9 million deaths of which half were due to a respiratory 
infection or diarrheal disease (3).  
Emerging infectious diseases, i.e., those that “have newly appeared in a population or 
have existed previously but are rapidly increasing in incidence or geographic range“ (4), 
constitute a major threat to public health.  While the total number of infectious disease cases has 
decreased in recent decades, since 1980, the rate of infectious disease outbreaks and the diversity 
of pathogens causing disease have been significantly increasing, even when controlling for the 
impact of globalization and increased surveillance (5).  This dissertation examines the impact 
that emerging and re-emerging infectious diseases have on children. 
Causes of Emerging Infectious Diseases 
 Numerous factors are implicated in the emergence and reemergence of infectious 
diseases including but not limited to human susceptibility, climate change, warfare, poverty and 
social inequality, microbial adaptation, and economic development (6).  These generalized 
causes are important for understanding the grander socioeconomic and environmental 
interactions precipitating emerging infectious diseases, however, they can be less applicable in 
identifying public health prevention and control interventions. For the purpose of this 




Antibiotic use. More than one fifth of all known emerging infectious diseases are 
associated with drug-resistant organisms (7). While advances have been made in the 
development of novel antibiotics, infections due to multidrug-resistant organisms (MDRO) are 
on the rise with an increasing burden of morbidity in children.   Multidrug- and carbapenem-
resistant Pseudomonas aeruginosa in children has been increasing steadily throughout the early 
2000s, with almost 25% of isolates tested showing multidrug-resistance in 2012 (8).  Similar 
findings have been reported in studies of carbapenem-resistant Enterobacteriaceae, with 
significant increases of an emerging resistant strain that was not identified in children until 2011 
(9, 10).   
Exposure to antibiotics has been identified one primary driver for the acquisition of a 
MDRO (11), which is further exacerbated by inappropriate antibiotic use.  A study on viral 
pneumonia found that most individuals were administered courses of antibiotics greater than 3 
days despite laboratory diagnosis with a viral pathogen and that those individuals were at more 
than 2 times the risk for subsequent acquisition with an MDRO (12).  Even though much of the 
current research has evaluated antibiotic use and MDRO colonization and not infection, 
colonization with an MDRO has been shown to not only increase the risk of an infection with 
that particular organism but also to increase the risk of colonization and/or infection with other 
MDRO (13).  Despite growing concerns over increases in antibiotic resistance, antibiotic use has 
largely remained consistent and there is evidence that broad-spectrum antibiotics are increasingly 
being used (14).   
Furthermore, some populations, such as residents of long-term care (LTC) facilities are 
more likely to receive not only more antibiotics but broad-spectrum antibiotics as well.  Prior 
research has shown that an estimated 47-79% of adults living in LTC facilities receive at least 
4 
 
one course of antibiotics a year at a rate of 0.4-23.5 courses per 1,000 resident days (15, 16).  
Similar findings were reported for residents of pediatric LTC facilities, who may be at greater 
risk for colonization and/or infection with an MDRO not only for increased antibiotic use but 
also for their comorbidities and complexity of care (17). 
Zoonotic transmission. Emerging diseases are two times as likely to be caused by a 
zoonotic pathogen as compared to a non-zoonotic one (18).  Over the past few decades, zoonotic 
infections have increased with over half of all outbreaks and almost two-thirds of all infectious 
diseases being traced back to an animal source (5).  While wildlife constitute the majority 
reservoir population of zoonotic pathogens, a significant proportion of these emerging infectious 
diseases spreading to humans are due to interactions with livestock (7). Middle East Respiratory 
Syndrome has been associated with domesticated dromedary camels (19), Severe Acute 
Respiratory Syndrome was sourced to wet markets in China (20), an outbreak of Nipah virus was 
traced back to industrial pig farming (21), and the emergence of antimicrobial resistant 
organisms has been linked to industrial animal agriculture (22).   As the volume of animal 
products consumed continues to increase worldwide (23), it is likely that livestock will become 
an ever-increasing source of emerging infectious diseases. 
Emerging Infectious Diseases Impact on Vulnerable Populations 
The burden of infectious diseases disproportionately affects vulnerable populations such 
as those living in developing countries as well as those at the extremes of age (1, 24). Individuals 
living in a low-income country are more likely to die from a respiratory infection or diarrheal 
disease than any other cause (3).  Many of these infections also have the greatest impact on 
children, especially those younger than 5 years old, with an estimated 6 million children dying 
each year as the result of an infectious disease, accounting for 68% of all childhood deaths in 
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those < 5 years old (25).  Both antibiotic use and zoonotic transmission have profound impacts 
on the emergence of infectious disease in these vulnerable populations, therefore this dissertation 
focuses on the acquisition of MDROs and the incidence of diarrheal disease. 
 Emergence of multidrug-resistant organisms in hospitalized children. Antibiotic 
exposure primarily leads to the development of MDRO in all populations, but it is children who 
oftentimes experience the greatest effects from MDRO acquisition, especially among those who 
are critically ill and/or hospitalized.  An estimated 5-10% of healthcare-associated infections 
(HAI) that occur each year in hospitalized children are caused by an MDRO (26).  Infection with 
an MDRO is known to increase the risk of mortality, lengthen hospitalization, and cost more 
than an infection with a non-MDRO among hospitalized patients (27, 28).  Critically ill children 
are at increased risk for a MDRO HAI due to their relatively high use of invasive devices, 
frequency of procedures, increased exposure to antibiotics, and prolonged length of stay (29-31).  
In addition to those risks, critically ill hospitalized children are likely to experience greater 
negative consequences of MDRO infection, with an estimated two times the risk of mortality for 
children with an MDRO versus non-MDRO HAI (32).   
Hospitalized children who are admitted from pediatric LTC facilities likely have an even 
greater risk of MDRO acquisition.  In addition to widespread antibiotic use in this population, 
these children are also more likely to have invasive device use, increased care needs, and be 
immunologically immature (17, 33).   However, previous research in pediatric LTC facilities has 
largely been limited to describing the prevalence of MDRO colonization, e.g., methicillin-
resistant Staphylococcus aureus and multidrug-resistant gram-negative bacilli (34, 35).  
Understanding the role that antibiotic use has in the development of MDRO will help to prevent 
the continued emergence of these pathogens in this at-risk population. 
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Diarrheal disease. One of the most common infections caused by zoonotic transmission 
is diarrheal illness, which was responsible for 1.6 million deaths worldwide in 2016 (36). 
Children carry an unequal burden of diarrheal disease.  It is a major cause of death throughout 
much of the world for children younger than 5 years old, particularly for those living in low- or 
middle-income countries.  In 2016, there were an estimated 1.1 billion new cases of diarrhea and 
an associated 446,000 deaths in children less than 5 years of age (36, 37).  Many factors 
contribute to the incidence of diarrhea in this population, including duration of breastfeeding and 
access to improved water and sanitation facilities, but of increasing concern is how interactions 
with animals may be associated with disease emergence (38).  Livestock and companion animals 
have been identified as a reservoir for many diarrheal pathogens such as Campylobacter spp., 
Escherichia coli, and Salmonella spp. (39), which are known to cause a significant proportion of 
diarrheal illness in children less than 5 years old (40).  Most studies investigating the interactions 
between humans and animals and subsequent diarrheal disease have focused primarily on 
developed countries with large animal agriculture and companion animal industries (39, 41).  
Since the burden of diarrheal disease primarily impacts developing and/or low-income countries, 
it is important to gain greater understanding of the interactions between humans and animals and 
how that may impact the incidence of diarrheal illness in young children living in low resourced 
areas.  Furthering our understanding of the human-animal exchange of pathogens may help to 
inform the design of improved interventions for the prevention of diarrhea, especially in 
children. 
Theoretical Framework 
This dissertation was guided by the epidemiologic triad of disease, which is comprised of 
four constructs: host, agent, environment, and disease (42).  This model fits this dissertation’s 
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investigation of the relationship between predictors related to the emergence and reemergence of 
infectious diseases (Figure 1.1).  The host includes factors such as age, sex, and comorbidities, 
and only refers to human hosts.  Agent includes the bacterial, viral, and parasitic pathogens 
causing infections in humans, e.g., MDRO, diarrheal disease pathogens, and Shiga toxin-
producing E. coli.  Environment refers to factors extrinsic of the host and agent that occur prior 
to the onset of an infectious disease.  The environmental factors influencing the development of 
disease can vary greatly.  For this dissertation, environment included healthcare factors (e.g., 
antibiotic use), interactions with animals (e.g., livestock), and characteristics of the lived 
environment, (e.g., use of improved sanitation facility).    
 









To gain further insight into the factors leading to the emergence and re-emergence of 
infectious diseases in vulnerable populations, with a focus on antimicrobial resistance and 
diarrheal disease, this dissertation aims to accomplish the following: 
Aim 1: To explore the relationship between antibiotic use and subsequent colonization or 
infection with a multidrug-resistant organism in hospitalized children 
Aim 2: To determine the relationship between prior stay in a pediatric long-term care facility and 
subsequent infection with a multidrug-resistant organism in hospitalized children 
Aim 3a: To assess the association of living in close proximity to animals on presence of 
diarrheal disease in children less than 5 years of age  






Prior Antibiotic Use and Acquisition of Multidrug-Resistant Organisms in Hospitalized 





Objective: Multidrug-resistant organisms (MDRO) cause about 5-10% of infections in 
hospitalized children, leading to an increased risk of death, prolonged hospitalization, and 
additional costs.  Antibiotic exposure is considered a driving factor of MDRO acquisition, 
however there is a lack of consensus regarding the impact of antibiotic factors, especially in 
children.  We conducted a systematic review to examine the relationship between antibiotic use 
and subsequent healthcare-associated infection or colonization with a MDRO in children.   
Design: Systematic review was conducted following the Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis guideline. 
Methods: Pubmed and Embase were searched for all English, peer-reviewed original research 
studies published before September 2018.  Included studies evaluated hospitalized children, 
antibiotic use as an exposure, and bacterial MDRO as an outcome.   
Results: Of the 535 studies initially identified, 29 met the inclusion criteria.  Overall, a positive 
association was identified in most studies evaluating a specific antibiotic exposure (81%, 
n=17/21), duration of antibiotics (75%, n=9/12), and number of antibiotics received (67%, 
n=2/3).  Those studies that evaluated any antibiotic exposure had mixed results (50%, n=5/10).  
There were wide variations among study sites, populations, and definitions of antibiotic use and 
MDROs.   
Conclusions: Published research evaluating this relationship is limited and was of mixed quality.  
Limitations include observation bias in recall of antibiotic exposure, variations in case 
definitions, and lack of evaluation of antibiotic dosing and appropriateness.  Additional studies 
exploring the impact of antibiotic use and MDRO acquisition may be needed to develop effective 




Multidrug-resistant organisms (MDRO) cause about 5-10% of infections in hospitalized 
children (26).  While there is no standard definition, a MDRO is generally an organism resistant 
to one or more classes of antibiotics to which it has been traditionally susceptible (43).  Such 
organisms have long been associated with increased risk of mortality, longer hospitalizations, 
and additional costs when compared with non-MDRO infections with the same species (28).    
Over the past two decades, the prevalence of MDRO has been increasing, particularly in 
children.  Researchers examining Pseudomonas aeruginosa found a 4% increase each year in 
multidrug-resistant strains beginning in 1999, with over a quarter of isolates multidrug-resistant 
by 2012 (8).  Similarly, studies of Enterobacteriaceae have shown significant increases in 
carbapenem-resistance, an emerging strain that was not consistently identified in children until 
2011 (10).  In the United States, pediatric multidrug-resistant Gram-negative enteric 
Enterobacteriaceae infections in hospitalized children increased 7.5-fold between 2007 and 2015 
(9).  Similarly, the rate of children hospitalized with vancomycin-resistant enterococcal 
infections increased from 53 per million in 1997 to 120 per million 2012, resulting in an average 
2 day longer hospitalization and an additional $8233 USD in hospital costs (44). 
About one third of children with MRSA bacteremia experience treatment failure and 
there is an estimated 50% increase in odds of a serious complication, e.g., need for 
extracorporeal membrane oxygenation or death, for every 1 day increase in bacteremia duration 
(45).  For hospitalized children who are critically ill, the consequences are more severe as their 
odds of death are two times greater if they have an infection with an MDRO as opposed to a non-
MDRO (32).  Furthermore, critically ill children are at increased risk for an infection with an 
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MDRO due to increased invasive device use and procedures, antibiotic exposure, and longer 
hospital stays (2, 29, 31). 
Although it is well-established that antibiotic exposure is highly correlated with MDRO 
acquisition, there is no general consensus on which drugs and dosages lead to resistance, 
especially in children (46-48).  Infections in children differ from those in adults and therefore 
often require different antibiotic management (49), which may lead to varying resistance patterns 
in children as compared to adults.  While individual studies have examined the relationship 
between antibiotic use and acquisition of MDRO in hospitalized children, but the data from these 
studies has not been synthesized.  In order to address the emergence of MDRO in critically ill 
children, it is necessary to understand the specific role of antibiotic use.  Therefore, we 
conducted a systematic review of the research literature to examine the relationship between 
antibiotic use and subsequent healthcare-associated infection or colonization with a MDRO in 
hospitalized children. 
Methods 
Inclusion and exclusion criteria. This systematic review was conducted using the 
Preferred Reporting Items for Systematic Reviews and Meta-Analysis guideline.(50)  The 
following inclusion criteria were used: 1) conducted only in children hospitalized at an acute care 
facility, 2) study predictor was a measure of antibiotic use, 3) study outcome was an HAI or 
healthcare-associated colonization (HAC) with a bacterial MDRO as defined by the study 
authors, 4) published in English, and 5) original research.  HAI and HAC were considered 
hospital-associated if they occurred > 48 hours after admission and before discharge.  
Tuberculosis and case studies were excluded from this review.   
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Search strategy. An initial search of two biomedical literature databases, Embase and 
PubMed, was conducted in November 2017 with subsequent searches conducted through 
September 2018. Search terms included combinations of keywords and/or Medical Subject 
Headings, when appropriate, which were linked with Boolean operators. Embase and Pubmed 
search terms are described in the Appendix.  
Study screening and quality assessment. Throughout the screening and quality 
assessment, two reviewers (MM and MB) evaluated each article.  Any discrepancies between 
reviewers were discussed with a third reviewer (EL) until consensus was reached.  The following 
process was employed to evaluate articles for inclusion in the study.  Firstly, articles were 
screened for duplication.  Secondly, the titles and abstracts were reviewed for relevance.  
Thirdly, appropriate articles were retrieved and the full text was assessed to determine if they 
met the inclusion criteria. Fourthly, references of included studies were hand searched to identify 
additional studies not identified during the original database search.   
The final included articles were reviewed using the Newcastle and Ottawa tools for 
quality assessment for cohort and case control studies (51).  While both tools have a maximum 
score of 9, not all items were relevant for each of the included studies.  To address the variance 
in denominators, scores were presented as percentages.  Studies were determined a priori to be of 
high quality if they scored > 75%, unclear quality if the scored 50 - 75%, and of low quality if 
they scored < 50%.   
Results 
Overall, 535 studies were identified during the initial database searches.  Twenty articles 
were duplicates, which resulted in 515 articles to be assessed for relevance.  After title, abstract 
and full text review, 20 studies met the inclusion criteria.  An additional nine articles were found 
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during hand searching of the 20 studies, bringing the total number of articles in the review to 29.  
The screening process and exclusion criteria are summarized in Figure 1.  The studies included 
4,598 hospitalized children in whom there were 4,606 HAI and/or HAC of which 34% (1,577) 
were due to a MDRO. A detailed description of each study is provided in Table 2.1.   
Study designs, sample, and association between antibiotic use and MDRO. The 
articles included in this review were all observational studies: 12 were cohort studies (seven 
retrospective (52-57) and five prospective (58-62)) and 17 were case control studies (63-80).  
The study sample for all articles were hospitalized children, although their ages differed among 
the studies.  Seven included specific age ranges (53, 56, 58, 60, 63, 74, 75), 10 included only 
neonates (52, 54, 57, 59, 61, 62, 65, 70, 71, 80), and 12 did not provide an age range for the 
children included (55, 64, 66-69, 72, 73, 76-79).   
Organisms included in the articles were Enterobacteriaceae (n=10) (52, 55, 59, 68, 69, 
74-78), Klebsiella pneumoniae (n=8) (54, 56, 60, 61, 67, 71, 79, 80), Escherichia coli (n=5) (56, 
66, 70, 79, 80), Gram-negative bacteria (n=3) (53, 63, 72), Acinetobacter baumannii (n=3) (62, 
65, 73), Enterococcus faecalis or E. faecium (n=1) (64), Pseudomonas aeruginosa (n=1) (57), 
Serratia marcescens (n=1) (61), and Streptococcus pneumoniae (n=1) (58).  For HAI, eight 
studies included all types of infections (52, 54, 57, 58, 62, 63, 74, 80), five were bloodstream 
infections (BSI) (53, 56, 60, 64, 79), one was urinary tract infections (UTI) (75), one was 
ventilator-associated pneumonia (VAP) (65), and one was respiratory tract infections (RTI) (55).  
All HAI were specified as occurring during the hospitalization, however only six studies 
provided HAI case definitions (52-54, 63-65).  Five studies examined HAC only (59, 67, 72, 76, 
78), and eight did not distinguish between HAI and HAC (61, 66, 68-71, 73, 77).   
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Ascertainment of antibiotic exposure differed across studies; 86% (n=25) abstracted 
antibiotic use from the medical record (52, 53, 55-57, 59-62, 64-68, 70-80), 3% (n=1) utilized 
both parental recall and the medical record (58), and 10% (n=3) did not explicitly state how 
antibiotic exposure was ascertained (54, 63, 69). Each study varied in its definitions of antibiotic 
use and HAI/HAC with a MDRO.  For the antibiotic exposure, measures of use included 
previous receipt of particular antibiotic classes or drugs (n=21) (52, 53, 56-60, 62, 65, 67-74, 76, 
78-80), receipt of any antibiotics (n=10) (53, 54, 56, 58, 63, 66, 72, 74, 76, 78), duration of 
antibiotic therapy (n=11) (52, 55, 61, 62, 64, 66, 72, 75, 77, 78, 80), and number of antibiotics 
received (n=3) (52, 75, 77).  The period of exposure timing varied from two weeks to six months 
(53, 55-58, 60, 62-64, 66, 68, 73, 74, 79); 15 studies did not provide any specific period (52, 54, 
59, 61, 65, 67, 69-72, 75-78, 80).  MDRO was limited to a specific bacteria (n=12) (54, 57, 58, 
60, 62, 64-67, 70, 71, 73) or grouping of bacteria (n=17) (52, 53, 55, 56, 59, 61, 63, 68, 69, 72, 
74-80).  The summary of findings of the impact of antibiotic exposure measures and subsequent 
MDRO acquisition is presented in Table 2.2. 
Quality assessment of included articles. The majority of studies had quality scores 
>50% (mean score 81%, range 44-100%) (Table 2.1), with 66% of high quality (n=19), 31% of 
unclear quality (n=9), and 3% of low quality (n=1).  Overall, case control studies were 
marginally higher quality than the cohort studies (mean score 82% and 79%, respectively).  For 
case control studies, all had adequate case definitions and the same method of ascertainment for 
cases and controls. Since all case control studies were medical record reviews, the non-response 
rate was not applicable nor reported.  For cohort studies, all were representative of the exposed 
cohort, had proper selection of non-exposed cohort, the outcome of interest was not present at 
the beginning of the study, and had adequate follow-up. The most common low-quality measure 
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was lack of definition of controls or ascertainment of exposure; 10 of the studies had either 
incomplete or no appropriate controls in their analysis.  The overall quality assessment for each 
quality measure is presented in Table 2.3 and the individual quality assessment for each study is 
provided in the Appendix.  
Discussion 
Overall, previous antibiotic use was significantly associated with MDRO colonization 
and/or infection in hospitalized children.  Half of the included studies reported a significant 
relationship between prior exposure to any antibiotic and subsequent HAI or HAC with an 
MDRO (53, 56, 66, 72, 78) and most of the studies examining the association between a 
particular antibiotic or antibiotic class found a positive association (53, 56-60, 62, 65, 67-69, 72, 
73, 76, 78-80).  Many of the agents evaluated were broad-spectrum, highlighting the importance 
of narrowing antibiotics to targeted therapy when possible.  These findings are in line with 
previous research which has shown that the continued use of broad-spectrum antibiotics 
increases the risk of development of MDROs (81).  Yet despite the growing concerns over 
antibiotic resistance, there is evidence that broad-spectrum antibiotics are increasingly being 
used (14).  Therefore, given the findings in this systematic review in addition to prior research, 
antibiotics for which there is concern for the development of drug-resistance, i.e. broad-spectrum 
agents, should be a main focus of antimicrobial stewardship programs.   
Duration of antibiotic use was also consistently significantly associated with MDRO 
infection and/or colonization in hospitalized children, even though there were wide variations 
among duration measurement.  Of the studies that evaluated antibiotic duration, 75% linked days 
of therapy to HAC or HAI with an MDRO (55, 61, 62, 64, 66, 70, 75, 77, 78).  These findings 
are consistent with similar studies in adults. Ruhe et al. found that prolonged beta-lactam use 
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increased the risk of penicillin-resistant S. pneumoniae bacteremia (82).  Similarly, longer 
courses of imipenem and ciprofloxacin have been associated with higher rates of HAI caused by 
drug-resistant Pseudomonas aeruginosa (83).  Additionally, prolonged antibiotic duration is 
associated with increases in adverse drug reactions (84).  Given research showing that an 
estimated 12-30% of antibiotic days of therapy in hospitalized patients is inappropriate (85-87), 
duration of therapy represents another important target for antibiotic stewardship initiatives. 
The importance of pediatric considerations in antimicrobial stewardship is warranted. 
Limited antibiotics exist for the treatment of MDRO infections and current efforts to develop 
new antibacterial drugs are lacking, especially for children (88).  Additionally, children exposed 
to antibiotics and subsequently develop MDROs may have long-term sequelae related to the 
exposure and infection. Recent research on the effect of early exposure to antibiotics on the 
microbiome has linked antibiotic use to wide range of negative health outcomes including 
obesity, metabolic disease, and autoimmune disorders (89).  Furthermore, antibiotic resistant 
organisms have been shown to persist in the microbiome of children exposed to antibiotics (90), 
increasing not only the individual child’s risk of infection with an MDRO but also increasing the 
potential risk of spread throughout their communities (13).  
While important insights can be gained from the studies appraised in this systematic 
review, there also are several limitations.  All of the studies included were observational and the 
majority were case control followed by retrospective cohort designs.  Therefore, ascertainment of 
antibiotic exposure may be subject to observation bias, especially for studies that relied on recall 
of exposure.  Even though the majority of studies cited the use of the medical record for 
determining antibiotic exposure, it was not clear whether the included courses were limited to 
those received during the hospital admission or if they also included other clinical settings, 
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potentially based on parental recall.  Parents of children with an infection, particularly if the 
infection is difficult to treat, i.e., caused by an MDRO, may be more likely to recall past 
antibiotic courses.  For those studies that used the medical record to determine antibiotic 
exposure, they may have been limited to only antibiotics prescribed within the hospital or 
healthcare system.  However, the most common prescription drug provided to children in the 
outpatient setting is antibiotics (91), which may lead to an underrepresentation of antibiotic 
exposure in studies that relied solely on ascertainment from the medical record. 
Also, there were wide variations in how antibiotic exposure was defined.  Only 52% of 
studies provided a defined window of antibiotic exposure, e.g., within 30 days prior to infection 
onset and less than half evaluated a specific measure of antibiotic use, e.g., duration of therapy.  
Due to the wide variation in definitions of antibiotic exposure, it was not possible to synthesize 
these results in a meta-analysis.  Additionally, none of the studies examined antimicrobial 
dosing.  One systematic review of antimicrobial dosing in adults identified low antibiotic dosing 
as a significant contributor to antibiotic resistance (92). In children, the provision of appropriate 
antibiotics is complicated by a variety of factors including weight-based dosing and limited 
antibiotic choices due to concerns about safety (93, 94).  Inappropriate dosing of antibiotic 
courses may partly drive the development of MDROs in this population.   
Research on the relationship between antibiotic use and MDRO infection in hospitalized 
children is limited and of mixed quality.   Antibiotic stewardship programs are considered one of 
the mainstays of MDRO prevention in children (95), however research evaluating the 
effectiveness of these programs have either not evaluated their impact on MDRO acquisition or 
have had little to no effect (47), Because hospitalized children represent a unique and vulnerable 
population and the impact of MDRO infections in this group of patients is likely to have long-
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lasting effects (96),  additional studies are needed to further elucidate the relationship of 
antibiotic exposure and subsequent MDRO HAI and to determine the best targets for 
intervention in antibiotic stewardship programs.   
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Figure 2.1: Flow diagram of study selection for comparison of prior antibiotic use and 
































Not original research: 2 
Study sample is not hospitalized children: 84 
Exposure is not prior antibiotic use: 26 
Outcome is healthcare-associated infection or 
colonization with multidrug-resistant bacteria: 40 
Case study: 1 
Not in English: 3
Duplicates: 20 
Titles & Abstracts Screened: 515 
Excluded: 
Not original research: 46 
Study sample is not hospitalized children: 21 
Exposure is not prior antibiotic use: 69 
Outcome is not healthcare-associated infection or 
colonization with multidrug-resistant bacteria: 173 
Tuberculosis study: 25 
Case study: 5
Full Articles Screened: 176 
Included in Quantitative Synthesis: 29 




Table 2.1: Description of studies comparing prior antibiotic use and subsequent health care-associated infection or 




Subjects Setting Study Design Antibiotic Exposure Outcome & 
Comparison 




548 children with 
Escherichia coli 








Antibiotic therapy or 
prophylaxis for > 4 wk in 








In cases compared to controls: 
antibiotics > 4 weeks in past 6 mo, aOR 
23.4, 95% CI 12.0-47.6; any antibiotic 




164 neonates with 169 
positive rectal swabs for 
Enterobacteriaceae; 127 













In neonates with ESBL versus non-





29 children ≤ 12 yr with 
neutropenia and fever 
for > 2 hr with 31 
episodes of Klebsiella 
pneumoniae BSI4: 16 










spectrum or 3 
cephalosporin antibiotics 
within 2 weeks prior to 





In children with CRKP versus CSKP 
bacteremia: broad-spectrum antibiotic, 
OR 28.0, 95% CI 4.0-194.5; 3 
cephalosporin, OR 11.1, 95% CI 1.3-





42 children hospitalized 
in the pediatric ICU; 10 
with MRKP7 
colonization or 





Case control Exposure to any 
aminoglycoside, 
gentamicin, tobramycin, 







In cases compared to controls: 
aminoglycoside, OR 12, 95% CI 1.8-
129; gentamicin, OR 4.3, 95% CI 0.7-
25.5; tobramycin, OR 6.4, 95% CI 0.6-
85.7; 3 cephalosporin, OR 17.8, 95% 
CI 1.8-411; 3 cephalosporin and 
gentamicin/tobramycin, aOR 31.2, 95% 




Table 2.1, continued: Description of studies comparing prior antibiotic use and subsequent health care-associated infection or 




Sample Size Study 
Sample 
Study Design Antibiotic Exposure Outcome & 
Comparison 









CRE8 and 126 CSE9 
3 children’s 
hospitals, 
USA, Jan 1, 
2011-Oct 15, 
2015 
Case control Fluoroquinolone, 
antipseudomonal, or 
carbapenem given >48h 






For cases versus controls: 
fluoroquinolone, OR 1.92, 95% CI 0.57-
6.52; carbapenem, OR 12.67, 95% CI 
3.75-42.8; antipseudomonal, aOR 5.20, 




70 infants with 76 
Enterobacteriaceae 








Number of antibiotics 
received, receipt of 3 
cephalosporin, duration 




In infants with ESBL versus non-ESBL: 
number of antibiotics received, p=not 
significant; receipt of 3 cephalosporin, 





167 neonates; 100 with 
ESBL S. marcescens 








Receipt of ampicillin/ 





For neonates with ESBL vs non-ESBL: 
receipt of ampicillin/gentamicin 
(p=0.002); days of 
ampicillin/gentamicin therapy, aOR 






76 children ≤ 18 yr with 
101 HAI: 47 MDR-






Case control Receipt of any antibiotics 





For cases versus controls: previous 





274 children ≤ 5 yr with 
invasive Streptococcus 
pneumoniae HAI: 99 









Receipt of any antibiotic 
and receipt of 
ampicillin/penicillin in 
prior 3 months 
PRSP versus 
PSSP HAI 
For children with PRSP vs PSSP HAI: 
antibiotic use, OR 1.2, 95% CI 0.7-1.9; 





Table 2.1, continued: Description of studies comparing prior antibiotic use and subsequent health care-associated infection or 




Sample Size Study 
Sample 
Study Design Antibiotic Exposure Outcome & 
Comparison 





65 children: 13 with 
CRE positive culture 
and 52 with no CRE 














 For cases vs controls: penicillin, aOR 
30.4, 95% CI 3.8-238.8; 3 
cephalosporin, aOR 7.3, 95% CI 1.8-
29.8; carbapenem, aOR 12.7, 95% CI 
2.6-61.5; fluoroquinolone, aOR 14.0, 
95% CI 2.9-66.6; T-S, aOR 8.2, 95% CI 
2.1-31.8 
Gaynes, 
R. P. et 
al., 88% 
16 infants infected or 
colonized with MR14-E. 






Case control Receipt of penicillins, 
mean total doses of 
penicillins, receipt of 
aminoglycosides, mean 







For cases vs controls: penicillins, p=not 
significant; mean total doses of 
penicillins, p=not significant; 
aminoglycosides, p=not significant; 





73 infants: 19 infected 
or colonized with ESBL 





April – June 
2001 
Case control Receipt of cefotaxime Infected or 
colonized 




For cases vs controls: cefotaxime, OR 




339 children with 
Enterococcus faecalis 
or E. faecium BSI: 39 





Case control Days of vancomycin 
exposure in prior 30 days 
VRE versus 
VSE BSI 
For cases versus controls: days of 





Table 2.1, continued: Description of studies comparing prior antibiotic use and subsequent health care-associated infection or 








Association of Interest 
Huang, Y. et 
al., 78% 
39 infants with 
nosocomial 
infections caused by 
E. coli or K.
pneumoniae: 22







Prior use of 3 
cephalosporin, days on 
3 cephalosporin, prior 




ESBL E. coli or 
K. pneumoniae
HAI
In children with ESBL versus 
non-ESBL HAI: 3 
cephalosporin, aOR 12.8, 95% 
CI 1.1-143.8; days on 3 
cephalosporin, p=0.190; beta-
lactamase inhibitor, OR 0.508, 




398 children: 176 
colonized with CR-
















For cases versus controls: any 
antibiotic, OR 2.9, 95% CI 
1.7-5.1; carbapenem, aOR 3.9, 
95% CI 1.6-9.2; ceftriaxone, 
OR 3.5, 95% CI 1.8-6.9; 
ampicillin, OR 3.1, 95% CI 
1.2-7.8; vancomycin, OR 7.04, 
95% CI 4.1-11.9; median days 




78 children: 26 
cases with IRAB18 
colonization or 
infection and 52 
controls with no 






Antibiotic exposure at 
15 days/30 days pre-


















no isolation of 
IRAB 
For cases versus controls: 
carbapenems 15 days, 
carbapenems 30 days, and 
aminoglycosides 30 days, all 
p<0.0001; other beta-lactams, 
p=0.01; aminoglycosides 15 
days, aOR 1.175, 95% CI 
1.025-1.347; all other 




Table 2.1, continued: Description of studies comparing prior antibiotic use and subsequent health care-associated infection or 








Association of Interest 
Kim, Y. et 
al., 89% 
142 children < 18 yr 
with E. coli or K. 
pneumoniae BSI: 49 







Within previous 1 




antibiotics other than 
extended-spectrum 
cephalosporins  
ESBL BSI versus 
non-ESBL BSI 
For children with ESBL 








Logan, L. K. 
et al., 100% 






and 60 negative 
culture controls  
Tertiary-care 
hospital and public 
teaching hospital, 
USA, Jan 2008-Dec 
2011  
Case control Antibiotic exposure in 
the 40 days prior to 







For cases versus controls: any 






78 children <16 yr 
with UTI19: 22 






Case control Mean days on 
antibiotics, intravenous 
antibiotics, and oral 
antibiotics; mean 





For cases versus controls: 
mean days on antibiotics, 
p=0.000; mean days on 
intravenous antibiotics, 
p=0.052; mean days on oral 
antibiotics, p=0.020; mean 
number of different antibiotics 
used, p=0.000; antibiotic 





Table 2.1, continued: Description of studies comparing prior antibiotic use and subsequent health care-associated infection or 








Association of Interest 
Nolan, S. M. 
et al., 100% 
78 children: 16 
colonized with VRE 
and 62 matched 
controls who were 
negative for VRE 
Pediatric oncology 
patients at a 
children’s hospital, 
USA, Jun 2006-Dec 
2007 











For cases versus controls: any 
antibiotic, p>0.99; 
fluoroquinolone, OR 4.65, 
95% CI 1.23-17.56; 
glycopeptide, OR 2.34, 95% 
CI 0.76-7.21; 3 
cephalosporin, OR 2.51 0.73-
8.57; aminoglycoside, OR 
1.54, 95% CI 0.47-5.08; 
antianaerobe, OR 0.85, 95% 
CI 0.22-3.31; carbapenem, 
p>0.99
Nourse, C. et 
al., 88% 
55 children: 14 
cases with VRE 
infection or 
colonization and 41 
matched controls 
negative for VRE 
Pediatric oncology 
patients at a 
children’s hospital, 
Ireland, Dec 25, 
1995-Mar 31, 1996 
Case control Number of antibiotics 









For cases versus controls: 
number of antibiotics, OR 
6.78, 95% CI 1.34-34.3; total 
antibiotic days, OR 4.07, 95 % 
CI 1.08-15.3; intravenous 
antibiotic days, OR 4.07, 95 % 
CI 1.08-15.3; days on 
ceftazidime, OR 11.5, 95% CI 
2.2-59.9; days on amikacin, 
OR 10.7, 1.4-81.5; days on 





97 children 1 mo – 
18 yr with GNB 
BSI: 31 CR-GNB 
and 66 CS-GNB20  
Pediatric infectious 
diseases department 
at hospital, Turkey, 
Jan 2014-Feb 2015 
Retrospective 
cohort 
Class of antibiotic used 
≤48 hr in the previous 











In children with CR-GNB 
versus CS-GNB BSI: 
carbapenem, p<0.001, 
fluoroquinolones, p=0.004, 
glycopeptides, p=0.001, no 
prior antibiotic use, p<0.001; 




Table 2.1, continued: Description of studies comparing prior antibiotic use and subsequent health care-associated infection or 
colonization with multidrug-resistant bacteria in hospitalized children 
Author, Quality 
Score 




Association of Interest 
Pessoa-Silva, C. L. 
et al., 67% 
383 neonates with 13 
ESBL K. pneumoniae 
HAI
Neonatal ICU, 











Incidence of ESBL K. 
pneumoniae HAI: 
antimicrobial use, IRR 
3.23, 95% CI 0.99-
10.49 
Rao, Y. B. et al., 
78% 
188 neonates with 
Pseudomonas 
aeruginosa infections: 
73 IRPA21 and 115 
ISPA22 






Receipt of imipenem, 
piperacillin-sulbactam, 3° 
cephalosporin, and/or 




In neonates with IRPA 
versus ISPA 
infections: imipenem 
treatment and IRPA vs 







Renk, H. et al., 
100% 
123 children with 167 
Enterobacteriaceae 
RTI23: 116 non-MDR-







Antibiotic therapy ≥ 7 days 









aOR 4.56, 95% CI 
1.69-12.30 
Rubin, L. G. et al., 
63% 
22 children: 8 cases 
colonized with VRE 








Case control Mean days of any antibiotic 
or vancomycin; receipt of 



















Table 2.1, continued: Description of studies comparing prior antibiotic use and subsequent health care-associated infection or 
colonization with multidrug-resistant bacteria in hospitalized children 
Author, Quality 
Score 




Association of Interest 
Sultan, A. M. & 
Seliem, W. A., 89% 
124 neonates with 
Acinetobacter 
baumannii HAI: 91 








administered for ≥ 24 in the 
14 days prior to HAI 




vancomycin; and median 
duration of antibiotic 
therapy in days 
CRAB versus 
CSAB HAI 
For children with 
CRAB versus CSAB 
HAI: carbapenem, 




22.6, 95% CI 1.1-
864.9; vancomycin, 




et al., 88% 
76 neonates with A. 
baumannii VAP27: 63 
CRAB and 13 CSAB 
Neonatal ICU, 
Thailand, Jan 1 
2009-Dec 31 
2014 
Case control Class of antibiotic therapy 









For cases versus 
controls: 
cephalosporin, aOR 
4.4, 95% 1.2-15.6; all 
other associations not 
significant 
Zaoutis, T. E. et al., 
100% 
140 children with E. 
coli or K. spp. BSI: 35 
cases with ESBL and 





Sept 30, 2003 
Case control Antibiotic use in previous 
30 days prior to infection 









For cases versus 
controls: 3° 
cephalosporin, aOR 














1T-S = trimethoprim-sulfamethoxazole 
2ESBL = extended-spectrum beta-lactamase producing
3ICU = intensive care unit
4BSI = bloodstream infection  
5CRKP = ceftazidime-resistant Klebsiella pneumoniae 
6CSKP = ceftazidime-susceptible K. pneumonia 
7MRKP = multidrug-resistant K. pneumonia 
8CRE = carbapenem-resistant Enterobacteriaceae 
9CRE = carbapenem-sensitive Enterobacteriaceae 
10HAI = healthcare-associated infection 
11MDR-GNB = multidrug-resistant Gram-negative bacteria
12PRSP = penicillin-resistant Streptococcus pneumoniae 
13PSSP = penicillin-susceptible S. pneumonia 
14MR = multidrug-resistant 
15VRE = vancomycin-resistant Enterococcus 
16VSE = vancomycin-susceptible Enterococcus 
17CR-GNB = carbapenem-resistant GNB 
18IRAB = imipenem-resistant Acinetobacter baumannii 
19UTI = urinary tract infection 
20CS-GNB = Carbapenem-susceptibility GNB 
21IRPA = imipenem-resistant Pseudomonas aeruginosa 
22ISPA = imipenem-susceptible P. aeruginosa 
23RTI = Respiratory tract infection  
24MDR-E = Multidrug-resistant Enterobacteriaceae 
25CRAB = Carbapenem-resistant Acinetobacter baumannii 
26CSAB = Carbapenem-susceptible Acinetobacter 
baumannii 
27VAP = Ventilator-associated pneumonia 
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Table 2.2: Summary of findings from systematic review evaluating the relationship 
between antibiotic exposure and subsequent infection or colonization with a multidrug-
resistant organism among hospitalized children  
 
Antibiotic Exposure Positive Association  
with MDROs 
Not Significant 
Any antibiotic, n=101 5 5 
Specific antibiotic, n=21 17 4 
Duration of antibiotic, n=12 9 3 
Number received, n=3 2 1 
1 n is the number of studies that evaluated the antibiotic exposure category; each study evaluated 




Table 2.3: Assessment of study quality using the Newcastle-Ottawa scale for case control 
and cohort studies 










28 (97) 1 (3) 0 (0) 
Selection of the 
controls/non-exposed 
cohort 
27 (93) 2 (7) 0 (0) 




19 (66) 10 (34) 0 (0) 
Adequacy of case 
definition or  
Outcome of interest 
was not present at 
start of study 





the basis of the 
design or analysis 




24 (83) 5 (17) 0 (0) 
Non-response rate or 
Follow-up long 
enough for outcomes 
to occur 
7 (29) 4 (14) 18 (62) 
Same methods of 
ascertainment for 
cases and controls or 
Adequacy of follow 
up of cohorts 
100 (100) 0 (0) 0 (0) 
Total Score,2 mean 
% (range) 
81% (44-100%) 
1 For each category of Yes, No, and Not Applicable, N is the number of studies and % is out of 
29, which is the total number of studies evaluated in the systematic review. 






Low Prevalence of Multidrug-Resistant Infections in Hospitalized Children who Have a History 




Background: Infections caused by multidrug-resistant organisms (MDROs) are a significant 
burden for hospitalized children.  Due to their multiple comorbidities, high acuity, relatively high 
use of invasive devices, and frequent antibiotic treatment, hospitalized children who have 
previously stayed in a pediatric long-term care (LTC) facility may be at increased risk for 
infection with MDROs.  This study aimed to assess the relationship between prior stay in 
pediatric LTC and infection with an MDRO. 
Methods: A retrospective cohort study was conducted of children ≤ 18 years old admitted to one 
of four hospitals in the New York City metropolitan area.  Data were collected from the 
electronic medical records for outcome and exposure variables including demographic, clinical, 
and microbial factors.  Infections included pneumonia, bloodstream, surgical site, and urinary 
tract infections.  MDROs were defined using the Centers for Disease Control and Prevention 
surveillance guidelines. Logistic regression was used to evaluate the association between 
previous stay in a pediatric LTC facility and infection with an MDRO. 
Results: During the study period, 77,454 children had 258,664 admissions, of which 1% 
(n=2945) had an infection.  At least 1 MDRO was identified in 10% of infections (n=305); the 
most common MDRO was methicillin-resistant Staphylococcus aureus (49%) followed by 
multidrug-resistant (MDR) Klebsiella spp. (19%), VRE (12%), MDR Pseudomonas spp. (12%), 
carbapenem-resistant Enterococcus (5%), and MDR Acinetobacter spp. (2%). Only 1 child who 
had previously resided in a pediatric LTC facility had an MDRO infection.  Prior stay in a LTC 
facility was associated with an increased likelihood of infection (OR 2.4, CI95 1.66 – 3.43), C. 
difficile infection (OR 2.57, CI95 1.26 – 5.25), days of antibiotic use (OR 1.01, CI95 1.01 – 
1.02), length of stay (OR 1.01, CI95 1.01 – 1.01), and death (OR 4.38, CI95 2.93 – 6.55). 
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Conclusions: MDROs do not appear to be a major contributor to infections among hospitalized 
children who have resided in pediatric LTC facilities.  However, these children were more likely 
to have other negative outcomes during their hospitalizations including increased antibiotic 
exposure, C. difficile infections, and prolonged hospital stays.  Further research is needed to 




Infections caused by antibiotic-resistant organisms are a significant burden for 
hospitalized children.  An estimated 5-10% of pediatric healthcare-associated infections (HAIs) 
are caused by multidrug-resistant organisms (MDROs), which are resistant to at least one class 
of antibiotics to which they are normally susceptible (26, 43). Infection with an MDRO has been 
shown to increase the risk of mortality, lengthen hospitalization, and cost more than infections 
with a non-MDRO (28). These negative outcomes become even more pronounced for critically 
ill children as those hospitalized in an intensive care unit with a HAI have almost twice the risk 
of death if their infection is caused by an MDRO versus a non-MDRO (32). 
 While efforts such as antimicrobial stewardship programs to limit the development of 
MDROs have been implemented, the prevalence of infections due to MDROs has been 
increasing over the past decade with a profound effect in children.  From 2007-2015, infections 
with multidrug-resistant Enterobacteriaceae significantly increased in hospitalized children from 
0.2% to 1.5%, and almost 25% of these infections were HAIs (9). Similarly, among pediatric 
infections caused by Pseudomonas aeruginosa, the proportion of multidrug-resistant isolates 
increased by 4% each year from 15.4% to 26% between 1999 and 2012 (8). 
Children who have previously resided in a pediatric long-term care (LTC) facilities may 
contribute to the rise of MDROs, particularly among hospitalized patients.   This population 
typically has multiple comorbidities, high acuity, relatively high use of invasive devices, and 
frequent antibiotic treatment, which may increase their risk for infection with MDROs (17, 29-
31).  Also, children receiving pediatric LTC are often transferred to acute care related to 
infections (97).  Given their increased risk factors for MDRO infection along with their frequent 
hospitalizations, the pediatric LTC population may be a source of transmission of MDROs from 
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the community and into the acute care setting, or vice versa.   Therefore, the primary aim of this 
study was to determine the relationship between prior stay at a pediatric LTC facility and 
infection with an MDRO versus non-MDRO among children hospitalized in acute care settings.  
Secondary aims were to assess prior stay at a pediatric LTC facility with any infection (MDRO 
or non-MDRO), antibiotic exposure, length of hospitalization, and death.  
Methods 
Study design and setting. We conducted a retrospective cohort study using data from a 
comprehensive dataset of electronic medical record clinical information for all patients admitted 
to four hospitals in a large academic healthcare system in New York City (Nursing Intensity of 
Patient Care Needs and Rates of Healthcare-Associated Infections; Agency for Healthcare 
Research and Quality, R01 HS024915).  The four medical facilities include a 221-bed 
community hospital, a 283-bed pediatric acute care hospital, a 647-bed adult tertiary/quaternary 
care hospital and a 914-bed adult and pediatric tertiary/quaternary care hospital.  All admissions 
from January 1, 2006 through December 31, 2016 were included for patients ≤ 18 years of age 
on the day of their admission.  Data were collected from the electronic medical record pertaining 
to demographic (e.g., age, sex, and admission source), clinical (e.g., infection type, invasive 
device use, antibiotic use, and length of stay), and microbial (e.g., pathogen and susceptibilities) 
factors.   
Outcomes. HAI and community-acquired infections were identified using electronic 
algorithms based on the Centers for Disease Control and Prevention (CDC) National Healthcare 
Safety Network’s (NHSN) surveillance case definitions, as previously described (98). The 
algorithms use data from the electronic medical record and administrative records including 
ICD-9 diagnosis codes, microbiology and microscopy results, and antibiotic susceptibility 
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reports to identify infections. The following infections were identified in this study: bloodstream 
infections (BSI), pneumonia, surgical site infections (SSI), urinary tract infections (UTI), and 
Clostrioides difficile infection. Commonly implicated organisms in both healthcare associated 
and community acquired infections were evaluated for antibiotic resistance including 
Staphylococcus aureus, Enterobacter spp., enterococci, Escherichia coli, Klebsiella spp., 
Acinetobacter spp., and Pseudomonas spp. For this study, an organism was identified as an 
MDRO based on common resistance patterns to key antimicrobial agents (43), as recommended 
for surveillance by the CDC’s National Healthcare Safety Network (99).  Multidrug-resistant 
Pseudomonas spp. was also included as an MDRO in this study as it is a common infection-
causing pathogen in hospital settings and is considered a serious antimicrobial resistance threat 
by the CDC (100).   Table 3.1 lists the organisms of interest along with the antimicrobial agents 
assessed to identify MDROs.  Only infections with susceptibility testing completed were 
included in the study.  Additional outcomes evaluated included days of antibiotic use during 
hospitalization, length of stay, and death. 
Exposures. History of stay in a LTC facility was assessed dichotomously based on 
administrative records indicating whether a child had ever been admitted to one of the four 
hospitals from LTC.  Other variables evaluated prior to onset of infection included demographic 
characteristics (age in years at time of admission, sex, and race), relevant comorbidities (diabetes 
mellitus or history of organ transplant), relevant treatments and interventions (antibiotics use 
prior to onset of infection, procedure in operating room, presence of tracheostomy, mechanical 
ventilation, feeding tube, urinary catheter, and central line), and factors related to hospitalization 
(admission to the pediatric acute care hospital versus any other and stay in intensive care unit).   
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Data analysis.  The relationship between prior stay in pediatric LTC and the outcomes of 
infection, antibiotic use, length of stay, and death were assessed using logistic regression with 
repeated subjects to account for multiple hospitalizations per patient.  For patients with an 
infection, the association between previous stay in a pediatric LTC facility and infection caused 
by an MDRO was assessed using the same method.  The potential confounders in the analysis of 
infection and infection with an MDRO were the previously described demographic 
characteristics, relevant comorbidities, treatments and interventions, and factors related to 
hospitalization.  Only the first infection for each hospitalization was evaluated for presence of an 
MDRO, regardless of other infections that may have occurred during the same stay, as this study 
did not aim to evaluate acquired resistance during hospitalization.  Statistical significance was 
defined a priori at 0.05.   
Results 
From 2006 through 2016, 77,454 children had 258,664 admissions, of which 1% 
(n=2,945) had an infection.  The most common infection was UTI (n=1,529, 52%) followed by 
BSI (n=839, 28%), pneumonia (n=313, 11%), and SSI (n=264, 9%).  Fourteen percent of 
infections were associated with more than 1 organism (n=426): 2 organisms (n=362, 12%), 3 
organisms (n=55, 2%), 4 organisms (n=7, 0.2%), and 5 organisms (n=2, 0.07%).  There were 323 
MDROs identified in 305 infections accounting for 10% of the infections in hospitalized 
children; 49% of MDROs were methicillin-resistant Staphylococcus aureus (MRSA) 
(n=158/323), 19% were multidrug-resistant Klebsiella spp. (n=61/323), 12% were vancomycin-
resistant Enterococcus (n=40/323), 12% were multidrug-resistant Pseudomonas spp. (n=40/323), 
5% were carbapenem-resistant Enterobacteriaceae (n=16/323), and 2% were multidrug-resistant 
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Acinetobacter spp. (n=8/323).  Table 3.2 provides the complete list of identified organisms 
implicated in infections.  
There were 1,128 acute care admissions of children who previously received pediatric 
LTC.  The prevalence of infection among children who had received pediatric LTC was 3% 
(n=30/1,128), whereas among children who never received pediatric LTC, the prevalence of 
infection was 1% (n=2,915/257,536).  Only one child with a history of pediatric LTC had an 
infection with an MDRO. The prevalence of MDRO infection was 0.09% (n=1/1,128) and 0.12% 
(n=304/257,536) among children with and without a previous stay in pediatric LTC, 
respectively. Children who had a history of residing in a pediatric LTC facility were 2.4 (CI95
1.66 – 3.43) times more likely to have an infection during their hospitalization compared to 
children who never received pediatric LTC.  The associations between the assessed covariates 
and infection as well as infection with an MDRO are provided in Tables 3.3 and 3.4, 
respectively.  Previous stay in an LTC facility was also associated with an increased likelihood 
of C. difficile infection (OR 2.57, CI95
 1.26 – 5.25), total days of antibiotic use (OR 1.01, CI95
1.01 – 1.02), length of stay (OR 1.01, CI95 1.01 – 1.01), and death (OR 4.38, CI95 2.93 – 6.55).   
Discussion 
These data did not suggest that MDROs were a major contributor to infections among 
hospitalized children who have resided in pediatric LTC facilities.  Rates of infections with an 
MDRO among hospitalized children at four New York metropolitan area hospitals were lower 
than reported in previous research (10, 101).  As this study only evaluated the first infection per 
hospital admission, the prevalence of these organisms would likely be greater if all infections 
were included.  Even though prevalence is relatively low, MDROs continue to be a significant 
concern among healthcare providers who work with this population.  In a survey of pediatric 
40 
 
LTC providers, multidrug-resistant bacteria were the most frequently cited concern related to 
infection prevention and control (102).  In our study, children who had a history of stay at a 
pediatric LTC facility had significantly longer duration of total antibiotic use during 
hospitalization and it is well established that antibiotic use is a primary driver of MDRO 
acquisition (11).   We were unable to capture outpatient antibiotic use in this study, however, 
children who have received pediatric LTC are known to frequently receive antibiotics (17) and 
are likely exposed to more courses of antibiotics compared to other hospitalized children. 
Therefore, these children would appear to be at greater risk to acquire an MDRO while 
hospitalized, however this was not substantiated by our results.  Since we only included the first 
infection for each acute care admission, it is possible that we missed the acquisition of an MDRO 
during the hospital stay, which may be more likely in the pediatric LTC population. Children 
who have previously resided in a pediatric LTC facility may not be at greater risk for infection 
with an MDRO upon admission but due to their significantly longer length of stay and greater 
antibiotic use during the hospital stay, they may have an increased risk of acquiring an MDRO 
throughout their hospitalization. Additionally, the use of an electronic algorithm based on the 
CDC NHSN surveillance case definitions may have been inappropriate for detecting infections 
for this study.  Children who receive pediatric LTC may differ in their presentation of infect ion 
due to their complex and chronic medical conditions, and previous assessments of surveillance 
case definitions have been shown to be inadequate in this population (33, 103, 104).  It is 
possible that the infections that were not captured in this population are more likely to be caused 
by an MDRO, e.g., respiratory and skin and soft tissue infections. 
In addition to longer exposure to antibiotics, children who resided in pediatric LTC had 
increased odds of infection, length of stay, and death.  This finding highlights the vulnerability of 
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the pediatric LTC population in acute care settings and may warrant specialized considerations 
for their medical care when hospitalized. C. difficile infection is increasingly concerning as 
antibiotic-resistant strains emerge, and children who previously stayed in a pediatric LTC facility 
may be at greater risk for this complication (105).  Previous studies have reported a rise in C. 
difficile infections over the past two decades, particularly in children with complex chronic 
conditions (106-108).  Prolonged antibiotic use is known to lead to the development of C. 
difficile infections (109), and longer hospitalizations may also provide greater opportunity for 
these children to become infected.  
There were several limitations to this study.   Since there was only one MDRO infection 
in children who had a previous stay in a pediatric LTC facility during our study period, we were 
unable to assess this relationship.  While this may indicate a low prevalence of MDROs in this 
population, it is likely that we did not capture many of the admissions from pediatric LTC 
facilities as this research was focused at one hospital system.  Children residing in pediatric LTC 
facilities often have complex and chronic medical conditions which require them to receive 
specialized care (33).  While we included one of the main pediatric acute care facilities in the 
region, it is possible that these children are being transferred other pediatric hospitals or to local 
community hospitals for emergent care.   
Also, we did not assess longitudinal trends of MDRO acquisition, including the potential 
for colonization.  Prior studies have shown that colonization with an MDRO only increases the 
risk of an infection with that particular organism but also to increase the risk of colonization 
and/or infection with other MDROs (13).  Future research should evaluate MDRO colonization 
in vulnerable pediatric populations, including those who have received care in pediatric LTC 
facilities. Lastly, we limited our organisms and infections of interest to those most prevalent in 
42 
 
the hospital setting and of greatest concern for development of multidrug-resistance.  Other types 
of antimicrobial-resistant organisms, e.g., multidrug-resistant Streptococcus spp. and infections, 
e.g., skin and soft tissue infections, were not accounted for and may be of greater impact in the 
pediatric LTC population (97, 110).    
  In conclusion, infection with an MDRO was not common in children with a history of 
residing in a pediatric LTC facility, however these children were more likely to have other 
negative outcomes during their hospitalizations including increased non-MDRO and C. difficile 
infections, C. difficile infections, and length of stay. While children who have resided in pediatric 
LTC are a small proportion of pediatric patients, they are a particularly vulnerable population 
and may be in need of specialized care considerations.  Further research is needed to evaluate the 
additional risks children at pediatric LTC facilities may have during hospitalization and the best 




Table 3.1: Key antimicrobial agents for determining multidrug-resistance of bacteria 
Organism Definition of Resistance 
Acinetobacter At least 3 antimicrobial classes of the following: β-lactams 
(piperacillin or piperacillin-tazobactam), aminoglycosides (amikacin, 
gentamicin, or tobramycin), carbapenems (imipenem or meropenem), 
cephalosporins (cefepime or ceftazidime), fluoroquinolones 
(ciprofloxacin or levofloxacin), sulbactams (ampicillin-sulbactam) 
Enterococci Vancomycin 
Klebsiella Ceftazidime, cefotaxime, ceftriaxone, or cefepime 
Pseudomonas At least 3 antimicrobial classes of the following: β-lactams 
(piperacillin or piperacillin-tazobactam), aminoglycosides (amikacin, 
gentamicin, or tobramycin), carbapenems (imipenem or meropenem), 
cephalosporins (cefepime or ceftazidime), fluoroquinolones 
(ciprofloxacin or levofloxacin), sulbactams (ampicillin-sulbactam) 
Staphylococcus Oxacillin 
Enterobacteriaceae Escherichia coli, Enterobacter spp., or Klebsiella spp. resistant to 






Table 3.2: Organisms causing infections in hospitalized children, 2006 – 2016 
Organism N = 3446 (%) 
Acinetobacter spp. 80 (3) 
Multidrug-resistant 8 (10) 
Enterobacter spp. 215 (7) 
Carbapenem-resistant 1 (0) 
Enterococci 460 (15) 
Vancomycin-resistant 40 (9) 
Escherichia coli 1281 (41) 
Carbapenem-resistant 6 (0) 
Klebsiella spp. 518 (17) 
Carbapenem-resistant 9 (2) 
Cephalosporin-resistant 61 (12) 
Pseudomonas spp. 320 (10) 
Multidrug-resistant 40 (13) 
Staphylococcus aureus 572 (18) 




Table 3.3: Characteristics of hospitalized children with and without infections, 2006 – 2016 
Characteristics Infection No Infection p-value OR (95% CI) 
N = 2945 (%) N = 255,719 (%) 
Previous stay in pediatric 
long-term care 
30 (1) 1098 (0) <0.001 2.39 (1.62 – 3.51) 
Demographics 
Age in years, mean (SD) 4.47 (5.53) 3.15 (5.48) <0.001 1.04 (1.03 – 1.05) 
Male 1495 (51) 133,355 (52) 0.28 0.95 (0.86 – 1.05) 
White 1044 (35) 80,976 (32) <0.001 1.19 (1.07 – 1.31) 
Prior conditions 
Diabetes mellitus 47 (2) 1896 (1) <0.001 2.12 (1.53 – 2.94) 
History of transplant 159 (5) 2468 (1) <0.001 5.72 (4.55 – 7.18) 
Invasive device use 
Feeding tube 48 (2) 1060 (0) <0.001 3.98 (2.97 – 5.34) 
Mechanical ventilation 560 (19) 10,007 (4) <0.001 5.77 (5.20 – 6.39) 
Urinary catheter 513 (17) 21,172 (8) <0.001 2.34 (2.11 – 2.58) 
Central venous line 670 (23) 19,696 (8) <0.001 3.53 (3.20 – 3.90) 
Hospitalization 
Admission to children’s 
hospital 
1949 (66) 124,328 (49) <0.001 2.07 (1.86 – 2.30) 
Stay in intensive care 
unit 
737 (25) 85,195 (33) <0.001 0.67 (0.61 – 0.73) 
Operating room 
procedure 
518 (18) 36,864 (14) <0.001 1.27 (1.15 – 1.40) 
Receipt of any antibiotic 890 (30) 135,330 (53) <0.001 0.39 (0.35 – 0.42) 
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Table 3.4: Characteristics of hospitalized children with infections with and without a 
multidrug-resistant organism, 2006 – 2016 
Characteristics MDRO No MDRO p-value OR (95% CI) 
N = 305 (%) N = 2640 (%) 
Previous stay in pediatric 
long-term care 
1 (0) 29 (1) 0.23 0.30 (0.04 – 2.20) 
Demographics 
Age in years, mean (SD) 4.47 (5.53) 3.15 (5.48) <0.001 1.04 (1.02 – 1.06) 
Male 163 (53) 1332 (50) 0.41 1.13 (0.85 – 1.50) 
White 128 (42) 916 (35) 0.04 1.36 (1.02 – 1.82) 
Prior conditions 
Diabetes mellitus 5 (2) 42 (2) 0.94 1.03 (0.42 – 2.56) 
History of transplant 18 (6) 141 (5) 0.68 1.11 (0.66 – 1.87) 
Invasive device use 
Feeding tube 8 (3) 40 (2) 0.16 1.75 (0.81 – 3.81) 
Mechanical ventilation 74 (24) 486 (18) 0.02 1.42 (1.07 – 1.89) 
Urinary catheter 69 (23) 444 (17) 0.02 1.45 (1.07 – 1.95) 
Central venous line 103 (34) 567 (21) <0.001 1.86 (1.42 – 2.44) 
Hospitalization 
Admission to children’s 
hospital 
230 (75) 1719 (65) 0.001 1.64 (1.22 – 2.21) 
Stay in intensive care 
unit 
89 (29) 648 (25) 0.10 1.27 (0.96 – 1.67) 
Operating room 
procedure 
67 (22) 451 (17) 0.04 1.37 (1.01 – 1.84) 








Background: Diarrheal disease is one of three major causes of death in children <5 years.  
Because livestock and pets are reservoirs of diarrheal pathogens, we assessed the relationship 
between animals living in or near the home and diarrheal disease in children.   
Methods: We conducted a secondary analysis of the Global Enteric Multicenter Study case 
control study of the epidemiology of diarrheal illness in children <5 in sub-Saharan Africa and 
south Asia. Diarrheal cases from 12/1/2007 to 3/3/2011 were matched 1:1-3 by age, sex, timing 
(within 14d of case) and location (same or nearby village) to community controls without 
diarrhea in the previous 7 days.  Cases and controls reported whether animals lived at or near 
their home and provided stool samples.  Associations between animals and diarrhea and diarrheal 
pathogens were assessed using conditional logistic regression.    
Results: Of 9,439 cases and 13,128 controls, 87% had ≥1 animal in their home.  Adjusting for 
exclusive breastfeeding, water source, sanitation facility, number of children <5 years in the 
household, and wealth index, any animal on a child’s compound decreased the odds of diarrhea 
by 33% (aOR 0.66, CI95 0.59 – 0.74).   Children with diarrhea who had an animal present were 
not more likely to have a positive stool culture. 
Conclusions: In contrast to prior research, having an animal at the home did not increase the risk 
of childhood diarrhea.   Risk of diarrheal disease in children in low-to-middle income countries 
may depend on type and number of animals.  Further understanding of human-animal pathogen 




Diarrheal disease is a major contributor to global morbidity and mortality for children 
younger than 5 years old, with an estimated incidence of 1.1 billion new cases and 446,000 
deaths in 2016 (36, 37).  Compared to children without diarrhea of the same age, those with 
moderate-to-severe diarrhea (diarrhea) are 8.5 times more likely to die in the following 60 days, 
with greater than two-thirds of diarrhea-related deaths happening after a week of the initial case 
(111).  In addition to increasing the risk of death, there are significant long-term effects 
associated with the incidence of diarrhea in these children.  Diarrheal disease has been associated 
with greater risk for subsequent infections and stunted growth (112, 113).  The risk for stunting 
increases with the number of cases of diarrhea experienced in early childhood (114).   
Many factors contribute to the incidence of diarrhea in children younger than 5, including 
duration of breastfeeding and access to improved water and sanitation facilities, but of increasing 
concern is how interactions with animals may be associated with disease emergence (38).  One 
of the most common infections caused by zoonotic transmission is diarrheal illness (36).  
Livestock and companion animals are known reservoirs of diarrheal pathogens including 
Campylobacter spp., Escherichia coli, and Salmonella spp. (39), and these pathogens are among 
the leading causative agents of diarrhea in children younger than 5 years of age (40). 
While previous studies have investigated companion animals and livestock as 
contributors to human diarrheal disease, few have investigated this association in sub-Saharan 
Africa and/or Southeast Asia, where diarrhea remains a leading cause of death in children (39, 
115, 116).  An analysis of Demographic and Health Surveys from 30 countries in sub-Saharan 
Africa found mixed results when comparing number of livestock owned and diarrhea in young 
children (117).  Similarly, a study by Headey et al. evaluating the relationship between exposure 
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to animal feces in the homestead environment and diarrhea in children younger than 2 years old 
living in Ethiopia, Bangladesh, and Vietnam did not conclusively identify a significant 
association (118). However, both studies relied on parental recall for the identification of 
diarrhea in the previous 2-weeks, which may have led to misclassification. 
Worldwide, the highest incidence of diarrhea as well as the greatest burden of severe 
disease is in Africa and Southeast Asia (119).  Increased understanding of the relationship 
between the presence of animals near the home and the incidence diarrhea in children younger 
than 5 years old can enable public health practitioners to implement better interventions to 
improve the health of vulnerable children in developing countries.  Thus, the purpose of this 
study was to gain further insight into diarrheal disease as it relates to the interaction between 
people, animals, and their shared environment.  The aim of this study was to assess the 
association between living in close proximity to animals and presence of diarrheal disease in 
children less than 5 years of age.   
Methods 
Study sites.  We conducted a secondary analysis of the Global Enteric Multicenter Study 
(GEMS), which was a multi-site case control study that described the epidemiology of and 
evaluated the risk factors for diarrheal illness in children < 5 years old living in sub-Saharan 
Africa and South Asia (120).  The GEMS study sites were located in seven countries: 
Bangladesh, India, Pakistan, The Gambia, Kenya, Mali, and Mozambique.  Enrollment in GEMS 
occurred between December 1, 2007 and March 3, 2011.  As per the global access commitment 
of the Bill and Melinda Gates Foundation, the funders of GEMS, these data were publicly 
available following approval of a written request for its use from the University of Maryland 
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(121).  As the data is provided de-identified no additional Institutional Review Board review was 
needed for this secondary analysis. 
Enrollment criteria.  The methodology of the GEMS study has been previously 
described (120).  Cases were defined as children 0-59 months of age who presented to a study 
site sentinel health center with acute diarrhea.  For each case, 1-3 children were enrolled as 
controls.  Children enrolled as controls were in the same surveillance region, enrolled within 14 
days of the case, had no history of diarrhea in the previous 7 days, and were matched to the case 
for age, sex, and location of residence (e.g., village or neighborhood).   This study included all 
22,568 cases and controls from the original GEMS study (111).  Previous analyses of the GEMS 
dataset have not assessed the association between living with animals and incidence of diarrhea 
across study sites nor have they determined the relationship between types of animals at the 
home and pathogens present in the stool.  Conan et al. examined animal-related exposures and 
incidence of diarrhea among a subset of children enrolled in GEMS in western Kenya, however, 
this was only among children living in households with domestic animals (122). 
Data collection.  During GEMS, an enrollment questionnaire was administered to all 
children and completed by the child’s caregiver.  This form included information pertaining to 
demographic (e.g., age, sex), environmental (e.g., living conditions, water sources, hygiene 
behaviors), clinical (e.g., symptoms, diarrhea frequency and consistency, treatment), and health 
care utilization (e.g., visits to health care center and health-related costs) factors.  Additional 
clinical data ascertained at the time of enrollment included physical characteristics (e.g., weight, 
height, and signs of dehydration) and laboratory findings from stool samples.  Laboratory testing 
of stool samples from both cases and controls included bacterial culture; multiplex polymerase 
chain reaction (PCR) assay for enterotoxigenic, enteropathogenic, and enteroaggregative E. coli 
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pathotypes; viral immunoassays; multiplex PCR assay for RNA viruses; and immunoassays for 
protozoa pathogens.  A detailed description of diagnostic microbiologic methods employed in 
GEMS has been previously published (123).  Further information regarding demographic and 
environmental factors were gathered during follow-up visits 60 days after the initial visit to the 
child’s home, which provided additional data on water sources and sanitation facilities.  
Variable definitions.  The primary predictor was the presence of animals in the living 
environment or compound of enrolled children.  Animal presence was assessed as a dichotomous 
variable, e.g., present or not, as well as a categorical variable.  The animal categories included in 
this analysis were goat, sheep, dog, cat, cattle, rodents, fowl (chicken, duck, or other birds), 
donkey and/or horse, and pig. The secondary predictor was animal type, i.e., the dichotomous 
presence or absence of each of at least one animal in each category.  Animal types were further 
categorized into two groups: livestock and companion animals.  Livestock were defined as cattle, 
goats, and/or sheep.  Companion animals were defined as dogs and/or cats.  Lastly, the number 
of types of animals present were evaluated, e.g., presence of fowl and sheep at a child’s home 
would be counted as two animal types present. 
The primary outcome was diarrhea, defined as at least 3 loose stools within a 24-hour 
period that occurred at least 7 days after any previous diarrheal episode and included one or more 
of the following additional symptoms: sunken eyes, loss of skin turgor, need for intravenous 
rehydration, dysentery, and/or hospitalization with diarrhea or dysentery (120). The secondary 
outcome was the presence of a pathogen in the stool of children who had diarrhea.  Pathogens 
were identified from fecal specimens and/or rectal swabs of cases and categories of pathogens 
(i.e., bacteria, viruses, and protozoa) and specific organisms (e.g., Shiga toxin-producing E. coli, 
rotavirus, and Cryptosporidium spp.) were evaluated. 
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Covariates evaluated as potential confounders include country of residence, 
breastfeeding, other children < 5 years old living in the household, access to an improved water 
source, and private sanitation facility.  These factors have been previously identified as risk 
factors for diarrheal disease (38).   Country of residence was the location of the study site for the 
study participant.  Breastfeeding was defined as a child being either partially or exclusively 
breastfed.  The number of children < 5 years old was evaluated as a continuous variable.  Use of 
improved water sources and sanitation facilities were determined using definitions from the 
World Health Organization (124).  Improved water source included use of piped water, 
boreholes or tube wells, protected/covered wells or springs, rainwater, and/or bought water (tank, 
bottles, etc.).  Private, improved sanitation facility included use of a flush toilet, ventilated 
improved pit latrine, traditional pit toilet, ventilated improved pit with water seal, and/or pour 
flush toilet and is not shared with another household (125).   A measure of wealth was also 
included in the analysis to account for the potential confounding relationship between animal 
ownership and higher socioeconomic status.  The GEMS study generated wealth index quintiles 
(WIQ) for enrolled households using principal component analysis (120).  Factors in the WIQ 
included home construction materials and ownership of household items and/or amenities, e.g., 
owning a television and presence of a flush toilet.   
Statistical analysis. Descriptive statistics for predictors, potential confounders, and 
outcomes were calculated for the primary and secondary aims of this study.  The primary and 
secondary aims were evaluated using multivariable conditional logistic regression, with strata 
defined by the matching of cases and controls.   Breastfeeding, other children < 5 years old living 
in the household, access to an improved water source, private sanitation facility, and WIQ were 
included as potential confounders (38).   The final models were determined using backwards 
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step-wise elimination.  All confounders except WIQ were retained in the final model if they were 
statistically significant at p<0.05.  WIQ was forced into the models to account for differences in 
sociodemographic characteristics between cases and controls.  All statistical analyses were 
conducted in SAS version 9.4 (SAS Institute, Cary, NC). 
Results 
From 12/1/2007 to 3/3/2011, there were 22,567 children enrolled in GEMS, including 
9,439 cases with diarrhea and 13,128 controls.  The average age was 17.7 months and 57% 
(n=12,821) were male.  Eighteen percent (n=4,097) resided in Mali, 17% (n=3,859) in 
Bangladesh, 16% (n=3,582) in India, 15% (n=3,359) in Kenya, 14% (n=3,096) in Pakistan, 12% 
(n=2,598) in The Gambia, and 9% (n=1,976) in Mozambique.  Eighty-seven percent of children 
had at least 1 animal present at their home.  The most common animal present was rodent 
(n=14,502, 64%) followed by fowl (n=12,151, 54%), cat (n=9,893, 44%), dog (n=9,598, 43%), 
goat (n=5,617, 25%), cow (n=5,267, 23%), sheep (n=3,771, 17%), donkey and/or horse 
(n=1,478, 7%), and pig (n=456, 2%).   
Relationship between proximity to animals and moderate-to-severe diarrhea.  The 
characteristics of cases and controls are described in Table 4.1.  When adjusting for exclusive 
breastfeeding, access to an improved water source, private access to an improved sanitation 
facility, the number of children younger than 5 years old living in the household, and wealth 
index, the presence of any animal on a child’s compound decreased the odds of diarrhea by 33% 
(aOR 0.66, CI95 0.59 – 0.74).  Only cattle, donkeys and/or horses, pigs, and rodents had a 
significant association with diarrhea.  However, these types of animals had differing associations 
with diarrhea, even after adjusting for confounding.  Presence of cattle or of donkeys and/or 
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horses at a child’s household increased the odds of diarrhea, being 1.20 times more likely with 
cattle (aOR CI95 1.10 – 1.30) and 2.17 times more likely with donkeys and/or horses (aOR CI95 
1.84 – 2.56).  In contrast, pigs on a child’s compound decreased the odds of diarrhea by 43% 
(aOR 0.57, CI95 0.45 – 0.72) and rodents decreased the odds of diarrhea by 12% (aOR 0.88, CI95 
0.81 – 0.95).  Similarly, having three to five different types of animals on child’s compound 
decreased the odds of diarrhea by 10% compared to children with zero to two different types, 
controlling for confounding (aOR 0.90, CI95 0.83 – 0.98).  Whereas the presence of six to eight 
different types of animals, compared to zero to two, increased the odds of diarrhea by 1.33 times 
(aOR CI95 1.17 – 1.52).  The complete multivariable results are provided in Table 4.2. 
Relationship between proximity to animals and pathogens causing moderate-to-
severe diarrhea.  The majority of children enrolled in GEMS had at least one pathogen 
identified in their stool: 83% of cases (n=7,860) and 72% of controls (n=9,419) (OR 2.07, 1.93 – 
2.23).  For children with diarrhea, the most common was bacteria (n=5,408, 69%) followed by 
viruses (n=3,202, 41%) and protozoa (n=2,864, 36%).  Sixty-three percent (n=4,965) of children 
with diarrhea had more than one pathogen identified: 36% (n=2,805) had two different pathogen 
types, i.e., bacteria and virus, virus and protozoa, protozoa and bacteria, isolated in their stool 
and 5% (n=404) had bacteria, virus, and protozoa isolated.  Bacteria was isolated in 84%, viruses 
in 35%, and protozoa in 45% of diarrheal stool specimens.  The complete description of 
pathogens identified in children with diarrhea is listed in Table 4.3.  Children with diarrhea who 
had an animal present on their compound were not more likely to be infected with a bacterial 
(aOR 0.96, CI95 0.82 – 1.13), viral (aOR 0.95, CI95 0.80 – 1.12), or protozoal organism (aOR 




Overall, in this study we found that having an animal present at the home does not 
consistently increase the risk of childhood diarrhea, and the relationship appears to be driven by 
the type of animal as well as the number of animals present.    In our study, the presence of 
cattle, donkeys, and/or horses was associated with increased odds of diarrhea, whereas rats and 
swine were not.  Other studies conducted in low- to middle-income countries have found mixed 
results when determining the relationship between childhood diarrhea and exposure to animals, 
particularly livestock (39, 117, 118, 126).  Given these differences, there may be additional 
environmental factors at play that are driving this relationship.  Large animals such as cattle, 
donkeys, and horses are reservoirs for different pathogens than swine and rodents.  In GEMS, the 
three most common pathogens identified in children with diarrhea were E. coli, rotavirus, and 
Giardia spp.  While it is well established that cattle are a reservoir for enterohemorrhagic E. coli 
(127), the overwhelming majority of E. coli identified were enteroaggregative, enteropathogenic, 
and enterotoxigenic E. coli.  Whereas there is some evidence that cattle may be a reservoir for 
some strains of enteropathogenic and enterotoxigenic E. coli (128, 129), no known animal 
reservoir has been identified for enteroaggregative E. coli (127).  Swine and cattle have both 
been implicated as reservoirs of rotavirus (130) and Giardia spp. is commonly found in 
domesticated animals, including livestock, dogs, and cats (131).  
The transmission pathway from animal presence at a child’s home and incidence of 
diarrhea is not well understood.  Contamination of drinking water with diarrheal pathogens may 
be a mechanism by which exposure to animals can lead to diarrheal disease.  Barnes et al. found 
that domestic animal ownership was significantly associated with contamination of drinking 
water with enteropathogenic organisms in Kenya (132).  In a GEMS sub-study, a subset of cases 
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and controls in western Kenya underwent additional assessments for potential zoonotic 
pathogens in the stool of domestic animals at the children’s homesteads as well as other factors 
that may increase or decrease the risk of diarrhea (122).  While Conan et al. (120) did not find a 
significant relationship between the pathogens identified in the domestic animals and diarrhea in 
children, in our study, having an animal appeared to be protective.  Conan et al. did note that 
engaging in basic health behaviors, e.g., handwashing after animal contact, reduced the risk for 
diarrhea.  Similar studies evaluating the impact of interventions aimed at improving water, 
sanitation, and hygiene conditions on childhood diarrhea have had limited success (133-136).  
However, these interventions did not account for the influence of animal contact on childhood 
diarrhea.  Broadening infection control measures to address preventive health behaviors with 
animals in and around the home may lead to greater decreases in childhood diarrhea.  
In this study, we did not find an association between presence of animals and type of 
pathogen in children with diarrhea when controlling for other known risk factors for diarrheal 
illness.  However, almost three-quarters of children enrolled as controls had a pathogen 
identified in their stool.  These children may have had asymptomatic infections, which have been 
identified in previous research investigating diarrheal illness in children living in low-resourced 
countries (137).  Asymptomatic enteric infections are common in children and their impact is not 
fully understood (138-140).  Previous research has linked asymptomatic enteric infections to 
negative health outcomes in children, such as growth faltering and malnutrition (138), leading 
some researchers to state that child growth rather than diarrheal incidence may be a more 
accurate measure of child health as related to sanitation (141).  In this study, we were unable to 
evaluate the relationship between animal presence at the homestead and colonization or 
asymptomatic infection with a pathogen.  Further research is needed to fully elucidate the role 
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that these pathogens play in the health of young children and the possible influence of animal 
exposure, especially for those who have additional factors which put them at risk for diarrheal 
disease. 
There were several limitations to this study.  Firstly, the GEMS study asked participants 
only about presence of animals on their compounds and not about whether children had direct 
contact with animals, animal waste, or specific pathogens.  Interaction with animals may be 
influenced by a range of household characteristics that are protective against the incidence of 
diarrhea, such as socioeconomic status.  Even though household wealth, as measured by WIQ, 
was not identified as a confounder of the relationship between animal presence and childhood 
diarrhea, it remained significantly associated with diarrhea in children.  While this particular 
measure of socioeconomic status did not rise to the level of confounding, there may be 
unmeasured confounding related to this construct that was not captured in this study.  Secondly, 
as this was a secondary data analysis, the purpose of GEMS was not to evaluate the impact of 
animal presence on childhood diarrhea.  Further investigation is needed to determine the impact 
of animals on childhood diarrhea, especially given the varying associations identified among 
animal types in this study.  Lastly, as the GEMS study is a case-control study, it is not possible to 
determine causality between animal presence and childhood diarrhea.  However, given the large 
sample size and the robustness of the study design, the findings offer important insight into the 
potential effects that living with animals may have on childhood diarrhea incidence. 
In conclusion, animal exposure may increase or decrease the risk for diarrheal disease in 
young children living in low-to-middle income countries, depending on the type and number of 
animal exposures.  Furthering our understanding of the human-animal exchange of pathogens 
may help to inform the design of improved interventions for the prevention of diarrhea, 
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especially in children.  Additional research is needed to gain greater understanding of this 
relationship. 
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Table 4.1: Characteristics of children with and without moderate-to-severe diarrhea living 







N = 9,439 
(%) 
N = 13,128 
(%) 
Exclusively breastfed 710 (8) 1,105 (8) 0.01 0.68 0.60 0.77 
Access to improved water 
source 
7,936 (84) 11,149 (85) <0.01 0.83 0.74 0.93 
Access to private 
improved sanitation 
facility 
4,714 (50) 7,235 (55) <0.01 0.89 0.83 0.96 
Mean number of children 
< 5 years old in 
household (SD) 
2.48 (2.20) 2.50 (2.37) <0.01 0.98 0.96 0.99 
Wealth index quintile 
1 (Poorest) 2,027 (21) 2,510 (19) Ref -- -- -- 
2 1,813 (19) 2,590 (20) <0.01 0.89 0.81 0.97 
3 1,993 (21) 2,834 (22) <0.01 0.89 0.82 0.97 
4 1,779 (19) 2,521 (19) 0.02 0.90 0.83 0.99 
5 (Wealthiest) 1,821 (19) 2,672 (20) 0.01 0.89 0.81 0.97 
Animal present on 
compound 
8,119 (86) 11,542 (88) <0.01 0.66 0.59 0.74 
Type of animal present 
Cat 4,086 (43) 5,807 (44) 0.16 1.06 0.98 1.15 
Cattle 2,223 (24) 3,044 (23) <0.01 1.17 1.08 1.27 
Dog 3,910 (41) 5,688 (43) 0.48 0.97 0.90 1.05 
Donkey and/or horse 705 (7) 773 (6) <0.01 2.17 1.84 2.56 
Fowl 4,980 (53) 7,171 (55) 0.83 0.99 0.93 1.06 
Goat 2,283 (24) 3,334 (25) 0.11 0.94 0.86 1.02 
Pig 314 (3) 142 (1) <0.01 0.56 0.44 0.71 
Rodents 6,041 (64) 8,461 (64) <0.01 0.88 0.81 0.94 
Sheep 1,603 (17) 2,168 (17) 0.95 1.00 0.91 1.10 
Number of types of 
animals present 
0-2 4,513 (48) 5,921 (45) Ref -- -- -- 
3-5 4,019 (43) 6,240 (48) <0.01 1.13 1.04 1.22 
6-8 907 (10) 967 (7) <0.01 0.76 0.67 0.87 
1Bolded characteristics are statistically significant at p <0.05 
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Table 4.2a: Multivariable analysis of animal exposure and children with and without 
moderate-to-severe diarrhea living in South Asia and Sub-Saharan Africa, 2007 - 2011 




Exclusively breastfed <0.01 0.68 0.60 0.77 
Access to improved water source <0.01 0.83 0.74 0.94 
Access to private improved sanitation facility <0.01 0.91 0.84 0.97 
Mean number of children < 5 years old in household 0.03 0.98 0.97 1.00 
Wealth income quintile     
1 (Poorest) Ref -- -- -- 
2 0.01 0.90 0.82 0.98 
3 0.04 0.91 0.84 1.00 
4 0.19 0.94 0.86 1.03 
5 (Wealthiest) 0.26 0.95 0.86 1.04 
Animal present on compound <0.01 0.66 0.59 0.74 
 
 
Table 4.2b: Multivariable analysis of cattle exposure and children with and without 
moderate-to-severe diarrhea living in South Asia and Sub-Saharan Africa, 2007 - 2011 




Exclusively breastfed <0.01 0.68 0.60 0.77 
Access to improved water source <0.01 0.83 0.74 0.94 
Access to private improved sanitation facility <0.01 0.91 0.84 0.97 
Mean number of children < 5 years old in household <0.01 0.98 0.96 0.99 
Wealth income quintile     
1 (Poorest) Ref -- -- -- 
2 <0.01 0.89 0.82 0.97 
3 0.02 0.90 0.83 0.98 
4 0.08 0.92 0.84 1.01 
5 (Wealthiest) 0.13 0.93 0.84 1.02 









Table 4.2c: Multivariable analysis of donkey and/or horse exposure and children with and 
without moderate-to-severe diarrhea living in South Asia and Sub-Saharan Africa, 2007 - 
2011 




Exclusively breastfed <0.01 0.69 0.61 0.78 
Access to improved water source <0.01 0.83 0.74 0.94 
Access to private improved sanitation facility 0.01 0.91 0.85 0.98 
Mean number of children < 5 years old in household <0.01 0.98 0.96 0.99 
Wealth income quintile 
1 (Poorest) Ref -- -- -- 
2 <0.01 0.89 0.82 0.97 
3 0.04 0.91 0.83 0.99 
4 0.12 0.93 0.85 1.02 
5 (Wealthiest) 0.18 0.94 0.85 1.03 
Donkey and/or horse present on compound <0.01 2.17 1.84 2.56 
Table 4.2d: Multivariable analysis of pig exposure and children with and without 
moderate-to-severe diarrhea living in South Asia and Sub-Saharan Africa, 2007 - 2011 




Exclusively breastfed <0.01 0.68 0.60 0.78 
Access to improved water source <0.01 0.83 0.74 0.94 
Access to private improved sanitation facility 0.01 0.91 0.84 0.98 
Mean number of children < 5 years old in household 0.01 0.98 0.96 1.00 
Wealth income quintile 
1 (Poorest) Ref -- -- -- 
2 0.01 0.90 0.82 0.98 
3 0.04 0.91 0.84 1.00 
4 0.16 0.94 0.86 1.03 
5 (Wealthiest) 0.22 0.94 0.86 1.04 
Pig present on compound <0.01 0.57 0.45 0.72 
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Table 4.2e: Multivariable analysis of rodent exposure and children with and without 
moderate-to-severe diarrhea living in South Asia and Sub-Saharan Africa, 2007 - 2011 




Exclusively breastfed <0.01 0.68 0.60 0.77 
Access to improved water source <0.01 0.83 0.74 0.94 
Access to private improved sanitation facility <0.01 0.91 0.85 0.98 
Mean number of children < 5 years old in household 0.02 0.98 0.96 1.00 
Wealth income quintile     
1 (Poorest) Ref -- -- -- 
2 0.01 0.89 0.82 0.98 
3 0.03 0.91 0.83 0.99 
4 0.13 0.93 0.85 1.02 
5 (Wealthiest) 0.18 0.94 0.85 1.03 
Rodent present on compound <0.01 0.88 0.81 0.95 
 
 
Table 4.2f: Multivariable analysis of rodent exposure and children with and without 
moderate-to-severe diarrhea living in South Asia and Sub-Saharan Africa, 2007 - 2011 




Exclusively breastfed <0.01 0.68 0.60 0.77 
Access to improved water source <0.01 0.83 0.73 0.93 
Access to private improved sanitation facility 0.02 0.92 0.85 0.99 
Mean number of children < 5 years old in household <0.01 0.98 0.96 0.99 
Wealth income quintile     
1 (Poorest) Ref -- -- -- 
2 0.01 0.89 0.82 0.97 
3 0.02 0.90 0.83 0.99 
4 0.14 0.93 0.85 1.02 
5 (Wealthiest) 0.18 0.94 0.85 1.03 
Number of types of animals present     
0-2 Ref -- -- -- 
3-5 0.01 0.90 0.83 0.98 




Table 4.3: Pathogens identified in children with moderate-to-severe diarrhea living in 
South Asia and sub-Saharan Africa, 2007 - 2011 
Pathogen Count (%) 
n = 7,860 
Bacteria 5,408 (69) 
Escherichia coli 4,003 (44) 
Enteroaggregative E. coli (EAEC) 1,846 
Enterohemorrhagic E. coli (EHEC) 6 
Enteropathogenic E. coli (EPEC) 1,084 
Enterotoxigenic E. coli (ETEC) 1,067 
Campylobacter spp. 1,171 (15) 
Shigella spp. 1,092 (14) 
Aeromonas spp. 655 (8) 
Vibrio cholerae O1 179 (2) 
Salmonella spp. 5 (0) 
Viruses1 3,202 (41) 
Rotavirus 1,747 (22) 
Norovirus 741 (9) 
Adenovirus 380 (5) 
Sapovirus 325 (4) 
Astrovirus 238 (3) 
Protozoa2 2,864 (36) 
Giardia spp. 1,786 (23) 
Cryptosporidium spp. 1,123 (14) 
Entamoeba histolytica 279 (4) 
1 Six children did not have viral testing. 






The aim of this dissertation was to describe the factors associated with the emergence and 
re-emergence of infectious diseases in children, in particular multidrug-resistant organisms 
(MDROs) and diarrheal disease.  To achieve this, three studies were undertaken to assess 
potential risk factors for infectious disease emergence.  The first study was a systematic review 
exploring the relationship between antibiotic use and subsequent colonization or infection with a 
MDRO in hospitalized children.  The second was a 11-year retrospective cohort study in four 
New York City hospitals evaluating the association between prior stay in a pediatric long-term 
care (LTC) facility and subsequent infection with a MDRO infection in hospitalized children.  
The third study was a secondary analysis of a case control study in seven countries in South Asia 
and sub-Saharan Africa examining the association of living in close proximity to animals on 
presence of diarrheal disease in children less than 5 years of age. 
Summary of Results and Key Findings 
Chapter Two describes the first study of the dissertation. The systematic review in 
Chapter Two summarized the existing literature related to the acquisition of a MDRO following 
antibiotic exposure in hospitalized children.  Twenty-nine research articles met the inclusion 
criteria and included a total of 4,598 hospitalized children and 4,606 healthcare-associated 
infections and/or colonization, of which 34% were due to a MDRO.  Overall, previous antibiotic 
use was found to be associated with MDRO colonization and/or infection in hospitalized 
children; a positive association with MDROs and a specific antibiotic exposure was reported in 
81% (17/21) of studies, duration of antibiotic use in 75% (9/12), number of antibiotics received 
in 66% (2/3), and any antibiotic exposure in 50% (5/10).  However, there was wide variation in 
the definitions of antibiotic exposition and MDRO, which limited the ability to synthesize the 
current research.  Having a comprehensive understanding of the components of antibiotic use 
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that lead to MDRO development in children would enable healthcare providers to create 
effective antibiotic stewardship programs for the prevention of MDRO infections. 
 Chapter Three describes the second study of this dissertation. The purpose of this study 
was to further understand the acquisition of MDROs in hospitalized children. To accomplish 
this, a retrospective cohort study was conducted to assess the likelihood of infection with an 
MDRO in hospitalized children who had previously received pediatric LTC, an especially 
vulnerable population. From 2006 through 2016, there were 77,454 children who had 258,664 
admissions, of which 1% (2,945) had an infection.  A MDRO was detected in 10% of infections, 
however, only 1 child who previously resided in pediatric LTC had a MDRO infection.   Prior 
stay in a LTC facility was associated with an increased likelihood of MDRO and non-MDRO 
infections, Clostrioides difficile infection, days of antibiotic use, length of stay, and death. 
These findings are important for several reasons. First, in this study, MDROs were not a 
major contributor to infections among hospitalized children who had previously resided in a 
pediatric LTC facility.  While this may indicate a low prevalence of MDROs in this population, 
it is inconsistent with what would be expected given the high risk characteristics of children who 
receive pediatric LTC.  One possible explanation is that infections are not being adequately 
captured by the electronic algorithm utilized, which was based upon the National Healthcare 
Safety Network surveillance case definitions (142).  These definitions were developed for the 
identification of acute care healthcare-associated infections (HAIs) and are not tailored to 
pediatrics.  Due to the medical complexity of children who receive pediatric LTC, the 
presentation of infection may differ from other hospitalized populations and therefore these 
surveillance definitions may lead to the underreporting of infections (103).  Infections that were 
not captured in this population may be more likely to be caused by an MDRO, e.g., respiratory 
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and skin and soft tissue infections.  Second, hospitalized children with a history of LTC were 
significantly more likely to experience a number of negative outcomes during their acute care 
stay including C. difficile infection, prolonged antibiotic use, increased length of stay, and death. 
Each of these outcomes warrants special consideration during hospitalizations among children 
admitted from LTC settings.  Of particular concern is the higher rates of infection with C. 
difficile among these children because of the emergence of antibiotic-resistant as well as highly 
virulent strains (105). 
Chapter Four describes the third study of this dissertation. In this chapter, the research 
aim was to determine the association of living in close proximity to animals on the presence of 
diarrheal disease in children younger than five years old. A secondary analysis of a three-year 
case control study was conducted to identify factors related to animal exposure and diarrheal 
disease in young children.  Of 9,439 cases with diarrhea and 13,128 uninfected controls, 87% 
had ≥1 animal in their home.  Any animal present on a child’s compound decreased the odds of 
diarrhea by 33%, when controlling for exclusive breastfeeding, water source, sanitation facility, 
number of children <5 years in the household, and wealth index. 
The findings of this study provided new knowledge to this area of research. Specifically, 
in contrast to previous studies (39, 117, 118, 126), having an animal at or near the home did not 
consistently increase the risk of childhood diarrhea.  This relationship appears to be driven by 
type and number of animals present.  Cattle, donkeys, and horses were associated with an 
increased risk of diarrhea, whereas rats and swine were not.  Furthermore, the number of 
different types of animals present initially had a protective effect against diarrhea in young 
children but there appears to be a threshold where the inverse becomes true and more animal 
types leads to an increased risk for diarrhea.  Therefore, it is important to consider the many 
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aspects of animal exposure when developing infection control interventions to limit the incidence 
of childhood diarrhea. 
Among children with diarrhea, there did not appear to be a significant relationship 
between the organism identified in their stool and the presence of animals at the home.  
However, this finding may be related to the inability to distinguish between diarrhea disease- 
causing pathogens and colonization with an enteric organism because the majority of children 
had a gastrointestinal pathogen detected in their stool, regardless of whether they had diarrhea.  
Prior research has shown that asymptomatic enteric infections in children are linked to negative 
health outcomes, including growth faltering and malnutrition.  Given the association between 
diarrhea and animal presence at a child’s home, it is possible that exposure to animals may also 
lead to asymptomatic infections or colonization with an enteric pathogen. While this study was 
unable to evaluate this relationship, this finding highlights an important gap in the current 
research and warrants further investigation.   
Strengths and Limitations 
This dissertation provides a detailed analysis of factors related to the emergence of 
infectious diseases in children.  By including diverse populations, i.e., children in both inpatient 
and outpatient settings worldwide, and multiple disease-related outcomes, i.e., acquisition of an 
MDRO and diarrheal disease, a thorough examination of the environmental, host, and pathogen 
characteristics implicated in infectious disease emergence was conducted.  Also, the three studies 
each included a large sample size, which increased the power and decreased the margin of error 
of the findings. 
There are limitations to this dissertation.  First, pathogen emergence is linked to time and 
none of the included studies were longitudinal in design.  Future research should build upon 
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these initial findings to elucidate how the relationship changes over time between the potential 
risk factors identified and the emergence of infectious diseases.  Second, Chapters Three and 
Four were both retrospective, observational studies and as such causality could not be inferred.  
Lastly, this dissertation relied solely on existing data and therefore the research questions in each 
study were not the primary purpose of the source datasets.  However, due to the large sample 
size and the robust study design of the parent studies, valuable insight into the factors involved in 
infections with MDROs and diarrheal disease was gained.  
Implications and Future Research  
Overall, these three studies provide a comprehensive look at various factors associated 
with the emergence of infectious diseases in children, particularly as related to MDROs and 
diarrheal disease.  Environmental factors, such as selective pressure of antibiotics and zoonotic 
transmission, were clearly associated with subsequent infection with an emergent infectious 
disease across diverse settings.   
These findings offer practical and clinical implications for limiting the emergence and re-
emergence of pathogens. In the prevention of MDROs, antibiotic use should continue to be a 
main focal point of infection control efforts.  The components of antibiotic use leading to MDRO 
acquisition are not well understood and further research is needed in order to develop effective 
antibiotic stewardship programs.  Among hospitalized children, the prevalence of MDROs was 
low, which may indicate that MDROs have yet to become a major issue in this population.  
However, given the many risk factors present for MDRO acquisition, there is great opportunity 
for the implementation of surveillance and prevention methods to thwart MDRO development 
and spread.   
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Infection prevention and control policies often focus on individual health behaviors, e.g., 
handwashing, or facility-level practices, e.g., antibiotic stewardship programs, but few have 
made recommendations for the community environment, e.g., interactions with wildlife.  While 
this dissertation examined the association between animal exposure and diarrheal disease, 
animals, particularly livestock, have also been implicated in the development of MDROs (143).  
Infectious disease emergence and spread is not limited to human-to-human interactions and this 
dissertation provides further evidence that a One Health approach to infection prevention 
measures is needed. 
Judicious use of antimicrobials through the adherence to antimicrobial stewardship 
programs, specialized infection prevention precautions for at-risk populations, and the 
encouragement of basic health behaviors, e.g., handwashing, have been well-studied and may 
greatly limit infections in children.   However, even though advances have been made both in the 
development of antimicrobial therapies and infection prevention and control interventions, 
infectious diseases, particularly among children, continue to be a major cause of morbidity and 
mortality worldwide (1, 2).  Children are often an under-researched population, yet emerging and 
reemerging infections in this population may have lasting effects.  Young children are 
particularly at-risk not only for infectious diseases but also for the negative consequences 
associated with infection, including growth faltering, development of comorbidities, and even 
death (25, 112, 113).  Developing interventions to limit these negative outcomes is a key 
component of public health programs and additional methods need to be designed to effectively 
mitigate the risks of emergent infectious diseases in children.   
Conclusion 
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In summary, this dissertation described three studies focused on identifying actionable 
risk factors to limit the incidence of emerging and reemerging pathogens in children. This work 
is important given the national focus on emerging infections, global initiatives to reduce 
morbidity and mortality from infectious disease in children, and the importance of antibiotic 
stewardship programs on the local, national, and global landscape. The findings from this 
dissertation provide new knowledge to the field and will inform future interventional studies to 
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Appendix I: Search terms for systematic review 
Embase search terms: 
('antibiotic therapy'/exp OR 'antibiotic therapy') AND ('antibiotic resistance'/exp OR 
'antibiotic resistance') AND ('hospital'/exp OR hospital) AND ('risk factor'/exp OR 'risk 
factor') AND ('pediatrics'/exp OR pediatrics OR 'child'/exp OR child) 
PubMed search terms: 
("drug resistance, microbial"[MeSH Terms] OR ("drug"[Title/Abstract] AND 
"resistance"[ Title/Abstract] AND "microbial"[ Title/Abstract]) OR "microbial drug 
resistance"[ Title/Abstract] OR ("antibiotic"[ Title/Abstract] AND "resistance"[ 
Title/Abstract]) OR "antibiotic resistance"[ Title/Abstract]) AND ("hospitals"[MeSH 
Terms] OR "hospitals"[ Title/Abstract] OR "hospital"[ Title/Abstract]) AND ("risk 
factors"[MeSH Terms] OR ("risk"[ Title/Abstract] AND "factors"[ Title/Abstract]) OR 
"risk factors"[ Title/Abstract]) AND ((("anti-bacterial agents"[Pharmacological Action] 
OR "anti-bacterial agents"[MeSH Terms] OR ("anti-bacterial"[ Title/Abstract] AND 
"agents"[ Title/Abstract]) OR "anti-bacterial agents"[ Title/Abstract] OR "antibiotics"[ 
Title/Abstract])) AND (“dose”[ Title/Abstract] OR “duration”[ Title/Abstract] OR 
“indication”[ Title/Abstract] OR “appropriate”[ Title/Abstract] OR “drug”[ 
Title/Abstract] OR “prophylaxis”[ Title/Abstract] OR “therapy”[ Title/Abstract])) AND 
(infan* OR newborn* OR new-born* OR perinat* OR neonat* OR baby OR baby* OR 
babies OR toddler* OR minors OR minors* OR boy OR boys OR boyfriend OR boyhood 
OR girl* OR kid OR kids OR child OR child* OR children* OR schoolchild* OR 
schoolchild OR school child[tiab] OR school child*[tiab] OR adolescen* OR juvenil* 
OR youth* OR teen* OR under*age* OR pubescen* OR pediatrics[mh] OR pediatric* 





Appendix II: Quality assessment of case control and cohort studies using the Newcastle-Ottawa Quality Assessment Scale 
















































































     N/A  88% 




       78% 
de Oliveira 
Costa, P., 2015 
Case 
control 
    N/A  63% 
Deeks, S. L., 
1999 
Cohort 





     N/A  75% 




      N/A  88% 
Met the Newcastle-Ottawa Quality Assessment Scale criteria for cohort studies; one star per category except for comparability which can




Appendix III, continued: Quality assessment of case control and cohort studies using the Newcastle-Ottawa Quality Assessment 
Scale 






























































    N/A 50% 


















    N/A  
63% 
Kim, Y., 2002 Cohort        78% 










      N/A  
100% 















      
56% 





Appendix III, continued: Quality assessment of case control and cohort studies using the Newcastle-Ottawa Quality Assessment Scale 




























































     
67% 
Rao, Y. B., 2018 Cohort        63% 
Renk, H., 2017 Cohort         100% 




    N/A 
63% 
Sultan, A. M., 
2018 
Cohort 






      N/A 
88% 




     N/A 
88% 
Met the Newcastle-Ottawa Quality Assessment Scale criteria for cohort studies; one star per category except for comparability which can be
granted two stars
